var title_f3_30_3552="MPS VII";
var content_f3_30_3552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucopolysaccharidosis type VII (MPS VII, Sly syndrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 253px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A three-year-old boy with Sly syndrome. Note the flared ribs, pigeon breast, hepatosplenomegaly, and umbilical hernia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sly WS, Quinton BA, McAlister WH, Rimoin DL. J Pediatr 1973; 82:249. Copyright &copy; 1973 Mosby, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3552=[""].join("\n");
var outline_f3_30_3552=null;
var title_f3_30_3553="Nondisplaced olecranon fracture";
var content_f3_30_3553=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nondisplaced olecranon fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Anteroposterior view of the elbow. (B) Lateral view of the elbow. A linear greenstick fracture line is evident on both views (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Erickson M, Frick S. Fractures of the proximal radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 7th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3553=[""].join("\n");
var outline_f3_30_3553=null;
var title_f3_30_3554="Large duodenal ulcer";
var content_f3_30_3554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86668&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86668&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large duodenal ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic view of a relatively large and deep ulcer in the duodenum, without evidence of a visible vessel or active bleeding (a black spot in the base of the ulcer can be seen).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3554=[""].join("\n");
var outline_f3_30_3554=null;
var title_f3_30_3555="Radical vulvectomy";
var content_f3_30_3555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radical vulvectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDze0vku7RJlPbkZ6GszU9QKHC8kda52wvJLVim47G6j3qCe5dnbce9cccOlLyNHUujQvNTk2MA+M+lYTS5YljnPrTbuRinBqtFDLIRsUmumMVEzuTSzYXavU1WrQt9KlfHmMqZ7dTWlDp1pGcMm/3LdTTukS5JGJErMwABJ9hWpa6fcOo/d7V65fitVHSIfJGiY/hxyKkacY5Iy2cE8AipcmyJTfQrxaYQR5sg47KP61ZEFvECx3tn+8c4/Coml4AIfA5442mopJyW27z6FeuanV7kPmZfMiRgBFQevb8qabglgASR0U+tZ3mMCSdo5+8ev5U1JfvE7skfMDwBRyByGg0oLcDC5xzyRTfN+ZmIPqc8ZFUPPIXIIyOAF70xpML3Az1Y0+UOUtNISMhw5HAwOufWqF2m5d2MHPGTTzKWXnJyckLxUbv/AA8D9c1SVi0httd7QEk+6Oh9P/rVcIZhviIbPY9KyplBb6U63uXgbIOR3BGQastq5deUo23cwI6YGKa0+fp7nkGpxdW1yoDrsb35X8D1FRS2IYloZB+PIP40cpOwz7Qd55JyeQBTDNk7jkk989arz280I+eNtvYjkfnUG8n60rFWuXhcAHOQec9KYZyBjcR6AVTLGkDGiwcpb80jPQ04TnaR6+tUw3rSl+KLDsW2mAHY/r+FRGTnsO/FVS5PTimZJ9aLBYuGQFs8Y7U0SZJOcfjVXmkxTCxaEoBPIJ9c0qygDqM9Kp4NBFAWL3nheBtyfWlE4xjPXrWeR60YOelAWNL7RjgMST1GetKZz93GfrWXtNLtPvSsFjU83pgDj9af52cAYA/3ayBvGeT+ddt8MfB154u1tI8tHYxHdPKegX0qZyjCLlIahzOyOr+FPhH+15zquqqU0u35wRjzCOgroviB4nRMpEAqqNsaD0rW8b69Z6JpkemaYBHawLtVR/EfWvCPEGsST3DMxLSt/wCOivPpxliZ88tjobVKPKhby8aadpJSWY+/eofP64xlvU1j/aem5TxT/tKnGTz24r0VFLQ5Wru7NQygYC7QTzgfyp4nxwGC45PFZYn5yG57YpwmIzkkmnYXKaouA2AHYDpwODT1lO7cWbj1FZaytwq7jVtVKxfv32Aj+I80uUXKWfM4Y/Kc8cimOPkHz7VHVicCqct8kYxCpY/3m/wqhLPJM2WYsaaQ1E0ptQjiGIx5jj+J+g+grOlnlupeWZ2NPtrN5iS3Cjk1s2ltFCg2qCx4B9aG7A2kZ9lpzNhpeB6VsxW6xxgdM8UnnRIMZAJ/Gle624wR0wecVm22Q5NlkhQAOAaGYbvYcdKoG6XeQCT9OlRfbAGzlT6EDmlysVmV3UqxDDDLTZAsuWGQR1FdFq1nFeIt9ZgBW++v901z8qmOQ+3BopzU1c6pwcXYjVEGOMn161PGcHAAwO3amAAnPbrmlDAKeuB69q0MmWBJ1weB3x0pWbngZJ6qvcVVL7hkkHnvwDSbvlAG7GM8dqVibFjeAq/MV6kHqR7GhpDjacdOd1V9x3YGB2wB1oLgNx69+oosFiVpCWyM+gOcClV87vmPXpUG/wCbJAGfXvTd3ynJPHHPamFiUHHICkn05zSMxweuenPb8KjzhM8DJ+gNNL4UD+XWgdh5cYA/H0FMMhxjof50xmGcZ/Goyec0WHYmaUkjdUZkJJJNMJ4ppPHIp2HYcXznPWmE06OGSQ4jRm7cCrUGk3k/KwkD1bii6QXS3KQfB4qaK7ZD1IrWi8M3DD97NEnOOOaux+FIsr5ly5yM4Van2kV1M5VYLdmRFqDD+KntJbTf62FST3Xg1tnwtZjA82bgZOMU9fDunox+edgD03ij2sTP20DnWsbaTmKZkPo4z/KoW02cAlAkg/2TXXwabYRSACIM3IwzE/nVuO3gQALAikLgHANHtF0QniEtjz14pI/voy/UVERXpTiNlKlEI4B+X+lU5rGxkAaS1jX/AGiMfyqfarsNYlPdHA46ijbxXayaHppC5jZAechzzTToGnZP+tHHALZp+0Rft4HGY5FAHWuwfw9YAk+ZKCD0zUDeGUZiIbnnsCuaftENVoPqctjjilK8cV0LeGbgNtWaI8epqvJoF6gwI1cf7LA0+ePcpVIvqYuKMVoy6ZcQ4EsTqfcVGLYFhzTTTKuikFpwQmrq26c5Iq9p2nSX15Fa2sbSzSMFVAOSaG7K4Xvohnhbw7eeItXgsLJCWc/M2OFHqa9/vptP8C+Gl0zT8KwXMsg6u1amg6Dp3w28Gma8MZ1adNzk9VHoK8T8Va7LrN68ztiLJ2qTivNcnip2Xwo6rKlHXcy/EOqT387ysck/dB7CucazZiSxOT61ou6gndKufbJqJp4V4yzD0AwK9GEOVWRyOTbuU/sAOMscfSmmwDHCMT9BmrEl4o+7GvHqc1E15M2VRmAPZeKqwK4z+ymHLssY/wBo4NOWC0gPzO8p9BwKhYyEkscfU800IXOACTQMstelRsgRYx7dfzqnK7kksGJq5BYyuCQMD1FaEGlAKGk55pOSQnJI58N/eB/Kpo2Uc/zrpo7CJQAIwTjuKsC1gBGY0/Kpc0S6iOcW8VRwQO/FDXo5yxI7fWumFrDz+7TI46UgtIChHlJ69KnnRPtInLtekjCnj0Apn2iRjwjE+9dV9it8cRqM8dKcbSNTkKuMelP2iD2iOUzcOMBDipoLC8uHConLHAAFdTbWJlmEUSbnPAAFev8AgLwJFp8a6jrO1cDcFbtWNXEqmjalF1HpseK2Vy9jMytzG3DKaj1WzUfvoOYm5+lW50S+tvtEON2ORUWn3CjME3Mbcc9qlS+2t+qOlx+y9uhh/cOD900rH1zwcZNaOp6eYHJXlD0NZuDjHRhXRGSkro55xcXZiOcY6H69Ka3UenHtihuFB4/Gk/j/AE561RAufm4zj9DTd31pQOSc80m0YIwM/XNACA4BP4cf1pN2B/gaVVOOBz9f60oQntxQAxmyRk80nXp2q7b6fPPIBHG2M9ccVpW3h9iN08gUc8DnFJyS3Jc4rc57HBPpU0NrPPgQxO+fQcfnXZW2lW0CYEYc5HLcmrqxYQbQAOeAOlQ6vYyliEtjkrfw/O/MzLHxn1Na1vodnE4LI0jA/wATf0rXMeABg5wKlWMrIBggZHHNQ5tmUq0mV7e3SNf3caqOfuripFjOw4AzgHnNaMNuTLgJlhngDNSC2fY2InyR6dazbRjzNsygCFOTgBs8c5qQL8inPcj+7+tXvsNyykfZ5DnBA209dNu9oHkN16Ef5FL2kV1L9jVe0X9xlychDjccdW4H596Y0TSOoQbmIBGRz+FdDHpaKg8+N5H5IHYVYa2S2kUwRDIUEnafyzR7WPRh7Cot4v7jGh0aVnHmukYPOCOfxpy6VDtZppztx0C4LZqtrGqSwgmWEhGbczDOcelYs3ii2YjNwxROFjZMgfjTTctUX7CfVWOtmntbQeXFHG4XDO0ZycelVlntbpFfascBbALYLD615xfa000rGEFUz9M0lprbwvk8jvnmr9i7XNfYeZ3V1YGMF7ZlYAHOQTj8ao72R8HKZA+UjOam0XxBFeuqyXGxyNrcckVspHFclkCmSX1J4YVPM46MxlTcdzD3EyYzzkfJjI6etPRsybd2Tk/KO341qGxg2MwB2DlguePrVWS2Ib7xK4JCsMfrT50RylZHznBDYU/dGD+NKrHYeR25HGPqKfscI27J2jH3cY9vejyyVJIOScbtvI/CndE8reyEDDy+2CfvDoaRljZQWjU5J5IAzSMCFDN8pJJ3Ff6U1wBtYhM7T94/yot2Gk0D2kMmMJgkfwZFex+AfCNn4L0RvEWuA/bZU3W8UpyYx6+xNM+EvgqEQjxN4iXbYwjdbROMbyP4iPSuO+Knji48Taq1raMRaIdqgHgj/CuWc5VX7OL0PVw9N04889zB8aeIrzxNqsu2RmhzkAnArhLvStTeYkqjDoNjjFdLap5J2qVJGc4GTUiu3fockfN2rqpr2atE5auKcpabHGNpdwpzO2wD2JqP7JEASXZ8DtxXaFsocKTxjpUE9pbyA+bCM9M42/1rT2j6kqt3OSCxL92NWPuCaPLllwAu1fYV0v8AZ1vt+QMmT3OTUiWiAKqgEgZ5p86K9qjAi0ws2Xyf61fg09EbGBmtRo8H06UKoD5PQf5+lS53IdVsqpEAp29QO1PAO3sOepqYD7wxwRTCoKHk0rk3GdVH49s/pQ7A4ODnHNOZRtHpn3//AF011BUZGeMZxnFACI6+Zx93sM9fwpoYgsB/WnsMNnHTFNziTGfwHHH9KBihiVOAcDnkVb06zn1C4jgtEZ3Y44FO0fTZ9RuBFAhIzyxHAr07S203wfZeaxWS7I6nsawq1VDRbnTRoOer2Njwr4TsfDNkL7V2RrkjIDdq5Xx549a4LwWb4jHAArmPFvjS91mZgJGEfpXFTTM7kD5m7+1Z0sO5PmqHbKcYrlgRaRem1uME/u2OCPT3rU1S12YuIOUbnjtXPouWwPyre0K8DKbW4O5G4Ge3tXVVi4v2kfmZ0ZKS9nL5E+nyC7j8iQjOOM1majZtbynjjsatXlvJp12MfcblWHetdQmqWWOPOUc+9Yufs2pr4WbcntFyP4kcc687gMDuBTQnzbe+en/16uXURt5mVx8ueas2lgZgGUFlz0UZrr5la5wy93cy0TOcenaporSWUYjXIB/Cuhh00RjcVRABnLHNSIYVJ/e8D0HaodTsZ8zeyMu10lXwZmzj+EVq29jBFtKxDPqRmnLLbo3zZYDgnOPxrTspIpyirahdzbdzEnH41nKTImp7kSR4YAcY7VZtrKaZwqxOxI4wtdXpwRHRIrceaCQSUDDHYj3rftdOvZ0UhBCSMM2ck/T0rnniIx3YqeDr1vhi/wAjhYdBu5Uc7EXABJZv/wBdaVloEIhMk2Z2Vtu2Pof64rv7Hw/DEvCj7oBBYnNakWnKijYqgdPu4rknjl9lHpUclk9asrehwtvos+xRbW8US7fmZgM/gKunQhuXzG444Xk12qaduY56fSrMenrGeuT9Olc0sXUfWx6FPK8NDdX9Ti49FjBbaGweuelWE0qNcAL+NdgLH5Bzwf8AZzTJLbCbV6Z9Kwc5PdnbClTh8CSOej0lCnIGPWo30qMe3p81bc9qQD5b4z7dKrpAQPnffjsetTzGyXmc7PYMgHl8r7c1GLAMm44J9+1dQYFVOceo5phtUA3EAZ6U7iZyUlhGWI2gg9sVm3vhrTbgEzWsLA9fkFdrLDGo+7z61TliHRQxz6CqUmtieRS3R5zc/D7RpeVtime6ORVST4a6UBnMwHs9elfZmzgR4+pqC4CRAmaSGNRx8zito4istpMl4ak/sr7jzb/hXGmIwZJbkEcgq/IrRh8NxwqI1luXA7s/NdXLrGkwgjzxI5/uqW5rPufEFomzy7a5YP8AdJUKG+lN160tHIqOAi9qf4FOHQnQuU3AEYYseopf7HwpbBKjvnimr4iky6paxbjwTK1VI9XvJbmKNwih84I5AHrS5pPdm0cByO8YJfcX1tY0XAAJ/ugZNQS/Kdvkjn+9xWRqWpzid/JuX+zg4QsuC34dqzTqE/3pZyO5JGMUKDY5YVrU2p4g24uIh9OtdV8MfAieI719Qv02aPanLuR/rCP4R/Wq3ww8Fal4zujPOr2+lRMN9w3G/wBl9a9E+Mniez8DeFLfRtICxXcqbI4E/gTHLn3NdFOMuh5WK5U+SybOF+NPj9ZWGh6MwjtYfkOw449K8qs4NuGIbzDySeh+lJpOkT6xLNO8y+f97Y7YLew9TV1bSSxLIAdp+XDclDXdBwp+6nqedisNVnTvH7iBMH5s52gnpjFMAKq7AgnGMoc5zV94WWEnqeACf6VHIMqARksecr2/Ct1I8MptlEZSCDkD5jk0xjlRgDrx8uRVhxjbu35+98gxj86hlQ7l3ehJG/8AUUxpkLqvy85OM/dpSzbgBu28DhRQ65lAyuQMfeNIFDzcbCOuMmgscJD5h69e5GKRZQxBIXPbmk8sBXIRSMdhzUQyI2KHGBj5U60WQyZCuS24c985NKI2IPTJ7ioS7Bed2WOMkgcUhmGB8wzn+Jv50WCw/nY2eOnf+tNYkoOm3PIJwPzpRLgcHPHXHSnGQFwCDn1HWgERt0U9cjpjP5Vf0rTHvZs8pHnLNnirGmaWbpvMkykK8ljxmp9V1aO3jNtZAADjisZ1G3yw3OulRuuaZo3GsW2iWpgslG4jlu5NcdqOpT3js87nb6ZqCaUuxeVtze9V1iadxuB29l/xq6dJR16nTKWnkRFmlztO1P73rT0QIoK7QPU8irCxDkZBHrjp/jTyg2ng565xitrnLKpfRGZHEcj8evSpYkKnPQircNo7DIU/Wr1pp5klVSCST0WhzQmyzabNUsTbT4Eo+43vWZaSTafelHyrocEetb8ccVuPlRgvIBA5zUerWJ1C38+Ff9LiXkd3Uf1Fcd1TlZ/C/wADupVPbx0+KP4oi1axS/tRc24BJGSB2rB0++n0+VogxCMeRWroeofZn2ycxNw49Pen+JtICBbq3w0Tcgiqpy9nL2U9nsXWpqtDnW/Uqm789TG5TGNxZOPzojgRoy+GkwwAC8Mw+lQ+H7I396IAY1YjJZ/T2FejabpVtZgBV8x8YLtyaMRXjR06mWHwcqut7IwNJ0GWdVM0aYYn/WDJA7YHrXeaP4dhghUBAo9+Sf8ACrGl2ymRSFGfXFdPaQc/1rya+KnP0PZoYKnS1tdjNN01IgFijCL645robSzQZG05x1xUmmwDAYgsfStVEweEA+lcnMdDKSWoQAjAJPTHWpRGFOOMn8RVwqAASv4etRFlD9FyBnmlcFqRIB0LAevFRSqC5yxIApt5qEMIbzD/AN89zWJfX7OHc/uoRycnBI96aTZcYNmheavHBiOP52XghRz/AIVyuueMJLJCyrEhGeH5rH1nxJBFE4sMyN0OOn51xdyt3q84MvC981vGEY6yO2lgr6y0R6noHiP+3NOWYKgk3FSASea0GlKyiJ4cSMOCTXl+nw3WkoPsUjgZzye9S33iLVoW3rA8sgH3gQKz5VJ6MU8K0/c2O9kvEjdhLIEx6Vi6l4ptNP8AvSiVs8BTz+VeU6j4l1Ce4KXBeNieUUc1q2WgXU1mJpSqGQ5+c5dauVNU1eRtDCRWtRnVT+NJ/MKRQhGH98f1pH17U2ClJUdn5CovIFZEFmtrayQG6Dg9inLE9fp0FXYriLTfmmZ1Zl2nYMZHeob7HS6FJL3Yjbqe+fm5lkkU5yFkI2/hWb9kQKfOdSSDjJJb/CrctzJcHzbcMtqD/GdoP+NZ4s5nuA9sy7Gb5mCEhT2HvmqjtqONorsWsNa2yrJuSMDchIxn3/8Ar1mvqTtPKZtsjAfKzEHaPw4q7q1lPJFGJmlVz8p35AyPSrEOkJGC0MYUkbMRqWye/J5oTVndico2uzI8+KSLzZQVbHGO9ULvU1jZfs7HIHr0FbF5ZwQwOiwuGLffLdvcdqrjS7eTJMj+aQqlWTbn2/Cqi47kSelznTqIACBcuTnrVrS9UstP1q1fX7CS6s1O9rffsWUdhuHbPXFM17RjbSINpRzzj1rNiLOv2e4UOnYN2+ld9FU5JSPHxs620XZd/wCtj2BPjBqUsqCzjtrPTolxHZ267UUD+dcPe6rP4r8RXWq608ksbjnZ1RR90DPQVyMls9mzNE5MJHQ9q3NFija2XezRqR271pXcYw5ovc83BUm6j5+hLN9ktm821Zx7OR+XFX7jUbWeMfa/MRx/q5/vEL2D+v1pXsYIrYvFEsiZ+8x5rIv3TyAF5A4IzXHCpd2PcVOM9GaUiyRruhKSoeVYcjHtVVtRBfbIyKyjHPA+vNVrCd4oTNbZI3bXiI+RuP0NO1Kyt9WjyoMFyBkKeG/D1Fd1Oolozw8flCd5wJvtEUpDLgrjBJ9aVoInlKkqrEiuLupNT0mXy5izxdAegNPXxEWXaQVJ7nmuxU7q6Z8/PDuLsdU8YSQ5cs4PCrjrUcKnLE8HnILfyrk5NckV9r7gPfr+dXbPWQW4cE98t1p8jRLouxubD5bZ5OMdzTHi+TBzycck1Ti1AbGUtu4wpFTpeJt+cBCDwCOtKzM/ZyQ2WPaqjA4zwwJqOVGDKCWBAxwvFTteQlcnbuHVcdqdFtndSifMTgYP6UXa3GosqOhd8YbqB16e1b2j6GvN1fYSIcgH0q3Y6ZbWEP2vUNobqq1lavq8l5lAdkA6AcVjKo5+7DY7aVG2styxrGsB1NvZ4SJeMisDIJPOfU1GXMh2pwvc1YW3YJ059KuMFBWNJ1FHVlcrubOCe3FWUlVFGVH0pTDgAYGc5pPLO1eRnnNaaHJOpzjhJGDnbgdaQFA5HHp0prx/MOnuTS+WcnLKfrS0M9DStQssbm3TdLjj3qSJCiOrx4djgfP0p0ZhjjURxqpJwBk/KPWmTTIBubylAXZhvT1rK9yrPZEIc7+GVP4QoJJ/3qfb6gLGVZHkGAeSWJLe9VmvTNIIbZiZHGARwMVrWWg2BEbauZbjIOFV9q7vf2qakoJWmdeFw9TmUo6WM/XrFYZlvrQA20/zHb0Un+lbPhlUvtNntZZAwXlUPVQfStqHS7d9Ma3jjUQsMBB0A9q5KKKbRtU2jPynIP8AeFcftPaw5L6rY9hUuSfNbfczNXsZ9I1EPHlSpypr0XwxeQ6nYRzqcy9HX0NQ6rp8OuaUs8WN5U7fY+hrivDuoyeHtbxPu+zu22VfT3pt/WqX9+JMP9lq2fwyPb9KtmZPSuitbQ4XrjuazNInt0tUlDBkdQykc5FGq+IGtT5UdsVccZlOB+VeTyyex7FOnKbtFHX25EcWRgcfWntMVj3Zry+78SvdLJBJekeYNuyH5SD7HrWJDrV9LLstXvpijZzNJuQj3FUqTe7OiGAnJ2PW7nU44mOP379wh4H1NY19rARJDPMkOOdo4rjPO12eNTI/kQE8mNccVSeOzaYrdSyzOeRzxx1BNPljE7IYCMdZP7jXv/GECEpaxtNIDwx/wrLh1PVLq6W5vUH2TO3aRlTx0NWNCs7MOJLm4gQLllQjnrwKLy5YzFQiFR0xxTdRRVka8tKGkUILSzNpKke1CGLcetVLB41RlwN+cZBqCWSWS48iP92CCWZug/8Ar0yysZX+0eUUxFydx9a52pS1bM5pm4yrtAbncM1Qvoig3JFuHfPenwXc9lF5ixiZipjI7qfUVraZBK9p9qvodueUQnPHrUSvDUx5nDcxn0S2msY7tgguDwEAwy+9Z1y7KBtklY55yc5NdJqM00qFItoJBwB1rnJvKhsJJN+Zsk8/zzTjNsqMpJ3ZG8cwQtAMz9tx4FRCyklMr6hdQoUTdtLdfYepotp41jV2uE3EZ+Y96STUbBEzKFectuaX0HoK6oJ7DdaXQlggcWnmQLJ5ZGdzL/KluLqJI0Ek0hVR8qqNoB/DrWbd+KBJF5aShVHQBarR6rAV+feWb+IgDH0rT2UuwczerRozagJLgu0cjlsYZ2J/Gul8O6jDb3BN1uaMjkZ6+1cWdQg8th5bsuOOTyfXNVpNWniwIoxjtmonSk9gcVNWZ2XiK4jndpgyct8yqMYFcpqV6BK0iMYyW3bclsfieaozz6jLIqzF4VbB+7g49avaXpP+lmQzq4DYVpVxkeuOxpwp8ivJjUVFF/RdCvfEEr3F1ItvbRLuLSnBbv0pmoaXE0ZjjRQBxnFbkFu7wB2nVMNt2Mxzj1xS3qo4I3Kx6ccVm62umhx1IuUtdjhbbSmmuHgmY+WGOFzwfxrfl017OxRDGj7Rw6nBx7irEXlxbwrAS5xtIyCD/Woz5zCRDJtB4HHWrnWnOw1h1F3iQSWbQRkSScMoZdhDBgfeqL6bHIAI87u4PeujsIVh06a3mWWVgAycZUf7RPUf1qnLAIFZGZQ4+ZW/vD2NLmcdUKz2Ofeza3QkqcAgkCqb328ATQsAuSrL1U+xrprmW0ePfJuznBiBxx65rBa0WSQpbsAvX5jXTSq/zCd35ETM93aNJcxSXEZBJKoWZVHGT7ZxXO6p4bMaJcWpzFJyOcgf59K6FoLzT332zsOoKq3UU+6vbRrQSxRyx3OQJedySZPJZexA7iu+jVa+FnnYzCwqK7Rwc1hNt2uuWXgf4VTeB4zypU/Su7udi3G1kK56KeQR7Gop4IHU5UY9xXaq/dHiVcJKBxsdxPFwGLD0aphfyYPyDn0Nbc2mxMQAoyfSptL8Ky6jdLHATsz8x9BV+1ja7Ob2bMrR4rzUbxIbSJsk8nJ4r0qxsrXw5aiS5YS3bDO08808Cx8M2gt7JVku8ct6Vz920kxNxdOTu6Z6n6VyTqOq9NjWMEtRNT1CW+lMkxO3svYVllTKwzwh6D1pt9cLChaQZP8ADGP61gvf3RnMhbjsvYVvThpoTOVtDpoBgnansPSrBzjsc9s9K5221ZBnzgwz27Zq2mqxkHLKABjA71TgzlnGTd2bAGcjHv1psi4A+VgAeoNZ41eEqRHhDjkZ+9To9QjkU7MY6Hcc1PIzPlZPIqkDDECkaM7uGwTiljcEEcsx6beAaeCA3ljl+656Uw2ObXUtTnYKs0jH0HFSCNy26aQyP3AOf1rp7Hw9I6hXyqn+FO/1rqdJ8FlgGkiEcY7t1NZTxVOGx6dPCye5yfhtCs6u8DegIGa72PSproRbjs53bV+Y/jW3ZeH4ok2wxg4/iIrotP09IFGFwf1PvXlV8Rzyuj1KUFCKRiWtibdUj2DYBnr1+tZHijRftMDTxL8yd67ia2aUsFGAOtMgs3uwY0GIeQSR941y87TujqSTR5h4fvTYzeVPkQucMD/CfWmeOtBEkZvbZRkffA/nW94o8Oy216qQoSXbC4HXNdsnhVY/Cbjl7hVAG49fUVpGtyzVSG5pPDxrU7M8U8OeLbvTLCWyLscfcbuo9PpWzHqlxqUaPIzGR+QQc1zni3SBY3fnWx/dseV7oe4Nbnge+sZ7V7a+ufs5XmMFAy57+9d1eEZQ9rBbl5di5Um8NV3W3miS0s45L5Ge5kO5vnULhgO4HrXSWsjWryQRMYoPvBHJOTVUMkN8psWWSVuOBwfbBpWvBK7rdRsJF/ujmvOqybPoYTtGyQ7UZZ5dqLMwHVV3fITUEji0jLyEMSvYA4qAefcShYYp2QDjfwK6jSfD6XFol3eJwGA2scD6e5rOztqY1qrVl0H6PoXmxpeTurIwwqkde+RVm60a1hfzLaJnnByctgCp4L9GJh07H2KLIy5wWOe3tRe6kWAjQAtt/hI4riqSlzWRzNVG7sev2dYGBjXcMlvr9axpCrSuYlAyeo6UpkkZWOAIG6sepqleXEs22GAKqLyzen/16cYNvUajJMuQKAwdypUvwAP1rc1m5X7OjRMoGwcLXDa5qUkHl4O7sRms+XxhJFaENbMyE4U7u9byoymlyoqVO7UmXdY1o2MG44J3YGeufWuSudbjZGBQs7flVPUL9tQulmuiFjz9xe1Zc8sYkbyQSueM16FDCR6rUyrYiNNF7+0Zhnyyqe+Koz3QY5kkLk/jVZ97n5jx6UqQbq9KNGEdWeVLF1Zu1NfeTxzxggnO3POKsxXqhm2IvPQtyapxwKWK7gD/ACrW07T7F5VS6umjB/jVen51nU9mkbUZ127u1izDOzkAksD/AAjiti2t2ZlYbUYc8AcVWittNtyAk4m/4EBmrC3aQEJbAkEdTXnzf8p6cW3sX0gRPmdjK/8Aebk1ajdiMJEPx4rKW4fALnJqYSswHUiuSSbepbikXJRNu+eVEHopzUPlHYS85znp0yPrUsZZgAEZj9KfPFmLEm1CeOe1RHfYxcmH2WyhKSRyeY4IyoUjvzkn+lXbae1cupcImcru5YfjWHcx7MkTkjvtFUGnKuCjA/U1vyOXULcy3O31G909nG1biTC7dxlAyPyrHnaGSPaqyxIQcZ+Y57VmxaoQhVV2R5G4IN2Pert08s+DvaQ4Ax0b24o5GtSIwtoYkduGkdZC7KcnjrirNvbJDblo082PIBbHKmp1PlSgOuD90q3GBT49NuGtZrmyL+UrbJJAvyAnpk9qvmuOou5lyGUliIyqjoeoNV5LX7ShVQYZCCC6chx6EVcvLhkhkheRfkwVx/Fk9BUdrbJcjbDcYLjJX1raF4+8jnnFOOpzxuVUJDcK7RKMYD989vSjLQ+YT8wUjBUhhj3q7eW6vKYLe1WWUqc4zwO5/CtDQPDxVBLqLBbcHIUHr9a9GNSLjdnkYlqm7dBNH0p9RAdoxHEOS54GK073UYbKM2ekL85+VpAOT7CqGveJIlQ2tnlYV4OwcmpfDev6Zp2lSXUVuZNYYkK0oykK+oHrScJNczR5t1JhPYJpcSz6tlrqQbo7Yn5vq/p9Kwru4aaVpHILH9B7VNJefbJXubiVpZHOSzHJNRTSxhTj9aaumbRpKSuyCa1TGZNuSM9e1UntLduDitC1u1k2I6jYoIDeoJ4H8/zqw5RlwiitHUlHRiVGE0YI0iCeUIJo4t3AZun4+lLe+G47KbybuV0mwDt29QehHqD61qywISM4q0t4n2VLS9HmQxg+S/VoT12j/ZJ7duo969rLoyXQhHVnO2+i2Lb0nlm3niNwAFU+49PftTRoaROdslwCDg4A4rZk8spwBzRHcncBIQTjb9fT9KftZ7ol0YJmcNOnICpO4UdCwpy6XKVxJdMfTAxWvvYjp+lL5hHcVn7eZX1eC6Hrul6LDbxbpioYc81sRwsxA6qOmantLRwxMx3k9Wx09q1YLZflC4G3kD0rxJTueioFGytxEnJBfPPb8KspAzDCjBI6ir5iVUwoH4DrT0jUBFj6kc1i5miRRe3JTy4wwX+IirWm2BhmkkkcsW4VB0Uf41cHlxsExn1qzbIzyB2BCjoP61DlY2UWomZqlpHK0LSqN6NleOlaM8W3SSz/ACqFJAIpk6+ddhFPCYyfepNSlWOxu5JsMFiICnvV0tTZXSjFHzR4ign1LxFdzohMLyeWQP51y88DWdw6tyCe1eo2EEdlBK04+aViRu9+9cDrcbJeXAeMrGWJjbsfUV62Gr3lyPYM2wdl7aGjiLZanDBZqhkna53c7sbNvt3BrVttVlB85n354G/rXJIm7Ix9KeZ5lCo7HA4Fa1MLFvQjCZpeC9qep6fri2ulSXcjAFWARMBju9R6DtUD6vdXVhDGXLLkv5OOBnvXN6A0dzpNzBdTMFRg6KMdfU0QawbS4aNIGkVDg4/xrz507NxitUexTqxcedHQpqk0EQDwssS4B5xiluNXTysxkKD1B61zS6ot1fmS7jYR54jU81JdatFISAiooHGOTWP1e3QHVi2dNps8d1IqXLSrBj+BgrZ7de1P1W7t9OtDHC6hByGJySa4W91KFbc/Z5JPM9iRWHPLPIcyMTnnk5rangnPW9kc9XGQpvuat7qUkzO0jmR24JPYe1UZbyRo1jyNo7Yqn1PzNRk7WZEJC4ya9BUFE5Z45y6WG3VyIlzJ36Adaz5LuV+I8Ivt1ouiZJ/m7DFPgjz2rthCMY6nz+IxNStUcYvQiSSUBsOfm65qWLzFxsdl/GpfJw2Ks2tq8uSilsdcU5Tildio4apOVkVUjZG3KSDWraTFR843D261YXSpl3LIhVwcEEdKYqC1fbL93tXFVrRqKyPXw2Flh3e5ciS3lHDD6Hg1aW0ZRmI4Hpmm6RAl5fLDGUcuCeDXYWXhqWWIMZSsQUEhsD8BXmVavs3Znqwlpc5mIup2yYHoSetbFokiDoPLI6kcVqXHhqJvkWY+YT8oZc8fhUC2Nzp0piu0JjB5x/PFY88Zq6Kcr6E8lxtjAAwcdqzbudfKJdix/u461oXvk7v3TE+xrPkgy2JxgEjBPYVmnZ3CMEkZsVpeXrFIAI4x94swXj6mljtUA2nO4H7oHUd+a2njSRgqFWCj+I4/GshZjBegSOCDkbulaqo5LQqzdySOxQ2sk0CsJYjnd5qjP/AeppsOp3MsbJNtEgbG5gdy/Src3lOFCqc9zmqdvZhLp3xnd2PSqp1bqzCMb6sV1vLhw1zKZAeNzckCmCe5sgwhlbaeCueCP611Gh20TkIQZDj5VJ4B9aoeL9OjtWT7PKZWZd0m2MqqHJ4HqMd6pO5j7Rc3JY5y7ktJIBJJ5nmKeV7VkR287OZLQOik8lzximnJ3yEb+cAHpURuZZpCodwc85PFejRo6bnk47G+ylyQWp02mwx2kT5YSSPgvIR0x2FZviPUZWDW6O0YXgiq0twCqRK5MXV25y1ZlyDNJjnB4q4JKRyRw0qidSruV7RSkJZ8uCTjP9adaQG7SRPmCBsnFSXYEcWB1HFaHhjEccjHHzHvXRObUHI56lOMZRghLbTSQNrH86syaNlRkuT9a3o4Y35RduR2pWjKjB5FcTrybuaKC2MGPSUVDtUg/WoW024Vj5b8e9dIUBXjIx1puwYyefrQq0uo1FLY5aWwvMfKc0WunSOzfaA656HPSuo2HBpsg6fLn8av272E4JmKmmRqc5J/3jmrKWoXoqge1TuSDwpApqt70nNvqHIkJhehppQY4X8aV3K4OaFmwOlSOx9DRRYZSxAX6ZzVmPaG4UH8KW2Axkcj0qRgSDtyMnivFlM71EBhVLPSQlQOD05PtUmwNtT7zdTmkuQsTBQMs3H41nc2hBNkWwy3ONxIB/OtV5BGm1eDjJPoKqzWccUXnbiHGMn+97VDqLiDR5ndgJphsGeOtUld2NZWnaxFocklws854BckD27UeJpI4/D97JkhtmM03w8NlmFJyT1NZvjXzW0gQLjE0oTGa6IpKVjaMOasku6OJ122j/4Ry3uRKm/eQsYPOMDn9a4vxHJEdKYz4LRR4VeM9eK7zxXon2TaVbhUUhR2B6LXmXiRHZmMq/M7YFb0bSnY7K8k6T5dbmbpVqLhFlH3WHX0q5f2MXliCJN88pwuOT9fpUK3KaVCltGDJL1IxXbeDNM3O17exiSeTsR9wegFddWpJPn+48ehhFKPs+25laZ4M1MRR+aHQPwNnO6o73wVfw33liSRI3ALMOa9htbtWZRO4Tb0BBbP4UmqazHbrsk8pkIwMx4IrjeIne51Ki4pRSPHpPDM1qv7q2l3ngyeZkn8+lUFhksoXhhsSJG43yLnHvmvSrnWrZm2Kylm6AHGaxtT1G2BZXAViKlYibeqNY0LrVHmzR3Em9pUGAuBx+oq5ax6bbCGS5jNzIMNJG5IB56Ajmr97cxsThhtjXhQOvpWNezxtEWlIHrXapOWwexileQyaODzGeLCqcnHpVGV0JZEb5CRuOetZ883myHaSFHTmmBSeMde9d0KDWsmeRWzGF3ClDTuN25kJHrVmFMNSJGa3tA0SbVJtsCFjjOAOtVWrKEdTDB4RzlzMoR2jykbB1rsvDXh6aa3a68tAqHfhuAcdRzW/H4Nu9IuWt72Hy5lwTnlfUEHoRXTaLYeTBMk8RO8F9g4AB7141XEtqx9DClCMeaBwypG4ZgvT2rKi0v+0b8q64jXkj19q6++sEt7/bEreUwBBI7n/wCvWn4Z0JjbfapFUCaXYgP3jjuPbiuZVOV3RpWjFK/c5OLwwIpkuLYmKReRsqS41XVbS6IkyYARlVGAK9QuNGaJAdnA7AdKyL3SopY2DIKylUcn7+py0qkVsc7ba2LiNmhgjMiMX3h8H/drMl8SyJdL9qg2opzktuNWNS8PiGQyWhaNup2nrXK3byPIYZxn3xiqp04SOuPKzrLzULO8hEkEiiZ/lCYA596qPbyzRJHeMUQDdgjPHt7VgafGIo+AHw2QK3Ly5MyQmNiqAEYHXnqDTcfZuyKUL6Ixr24bTrkJES0bL1P8hUFgjahfDzVfb2A61eh8xJ13xCVAchWG4V0vh2aKO7NxJbRl1P8Aq5EwrD0xWkpqEb21BxcVZFJdNe3bYMyREZGB0qKdVUhFyw6k1v6tqERZ5FjSFT0Vegrnlja5lEiFtvpWFOTm7hTVlqWIX8va2SMelaOo6otzpEkdwyeYCPLwnLn3PoBWU7oPkOQV4IqvHLG1yqzhhDnlsdBW6TInR5nzM5eRns9QcSoPInOSAOAfaoJUjO51OBuxwO1dB4tmtJygsYvLRWwoPLEepPqa52SQPEkWzlRgEcc57+tehRk2rnHOhFvma1/IdLcLDZFFRWaQ8N3AFVkVgqEnjtxV9YVEEkjKA2cKB61RnkaMKrD5q6II5qkkivfYG2PvnmtCwzHacAk9cCspgTIS/J6VqW74RVXtxW1RWgkeNKXNUbNWzuZFUE5Hse1aS3KumSD71gRynOM/jVhHBGc/hmuOUC0zaXB+7370Mp5rOtrsRDbjp2rRSRZBnPWs3FopsZt546imv94gYDe9IchioZuRULblUZZifcUJCbFc5GDioioxwME0quxJDKCKQghs5AB9a0FdkTQ54J/GkaM4wcY+lSsdpywFQNKMkDBPpmgR9KnAXCj2FVd62yHLs7g8KvPNWpoV3LkswB5CjgVQuSZLpEQbVU4UDue5rwGm3dns01fRGnpjOymacYJHFNtla5v2kYEon3fanbyEEMf3jxVxAIoVSNfmPAp3uaP3b26izR/acjcVRDyR3rn/ABTMWsViR48tMEAJ5GOc10kuIoNqelcLqNu8ksJdyyySnDEZxjrxW1H40Vh0pat6I39AVre0QNnPTJo1u3S41CxD7RFHmeQk9FHWn6cxdQBzgnGKoeMQy3lquR5bxgtWsdWzelFyrpXs9fyOX8aXMskEs7thpeY/QDoK8p8R+c95biYbTKN4A9O1er+I2iSJftMAjKqMfNnOBwfxry+yg+2+I4FlyIo2BZmP3RmtsOrNs7akP3aSNXw/4aMtyt/drldoCj0rtbeDy0LqSqdOO9V2uofKMQJVF+VEzjjPU1Sv7+RYttqGSxQ/vHzycemaicpSKhTUY7DtY1RbckKxZ+3Nc1qXiN5IAGBCqSOTms3xKJJ72abSUuI7UjMaTHc7+tcrKZmfy2kznlsdq6KGG5lds5cTjqVBJNavoa97rUchzg7x90jqKr32pTC2WWYhd3ChupHrSWlqpBeQYhQZY+vtXP6tdtfXhP8AAvCgdAK6aNGM5cq2R5+Mx86NLmejeyLg1TyhKCdzMu3gdKz5ZZLg/OeOwFEceeo5qaOEg89K9BQhT1R406+IxSUZPT+tyFIyMVYRCeB1q1BavIQFH6Vo2OnMsw81SvPymuepiYo9DC5Y95FXStPkvLkRAiPsWfgCvcPhtpA0+wtbxYhdYYM6BcFDzgg9zwa5XSLOB1iP9nn5FxI65AY5659a7vwzOLLEdnK1vIELN5uSNw6bcdMjjmvHxGIc2ey8Ly0uWP8AX3G74huY7m1iso0JVZPNGRyFxwCe9Z7rNdyPujCyMMKiR8dK0WljtIpWnaOa7uPvBRxEuQcg9yf0qzf6qL0wSRr5N3FGI/NjOAy4xyPXFcEquru/kTTi6aShHTv/AF0OK1iF7myk3qQ9umCfQZ4rZ8IkStpYkXDMC3bnKnpWd4gQxQS4RumG4qz8L7qB7uG1voxIkZIUscbVznII7itab9okb4mH7lyS2/yPSrzTxLpk0kaBETlnY4XAH864K82qGyGGRwccV6L4t1G3TT5LNJ2kmcBcAcAZ6nHftXnVzb+e20Z475q8XCNNqMXc8fLk5x55rToc/PGbn5FGBnDEVQvNBt5EZdgJ/WurS1S3+XsaW6twYsR4yTge1csZNHpNpuyPKJ/D0trcv9jyxyMqxwKS7T7NcJGVPmZxz0FeiG0EO7dySeTjrXN+JLMNsmixlflHHauiNbm0ZpCTUrdDIiO13VNr7D1HcVce9jaIIyOnoBUOn2CmCRy+2bsCOtWghYKuzJ70m1exs4p7lFFglYsokc/7Z6Va8gbOcqnfFWrHTm887yqg88mtCeKJUKDGQMe1NtJ6ESaTsjnXwv72Z1dzxjPOPpVDWZ43LypF5I6iMHgcVpFdocsqq2TyOg+lczqsvUHkMcD3966aacmXdbmZc+ZKxAJ3D1HFLKi2OpCNsMQAMdeak+yt56ouTuUHitK1shb6jHcSNG0Maibk5yew+vtXdFrY4a8uVN9TOup/ImUEq6LzjHBNZjsZ7iSZwAByB71Z1Ob7TcyykfKT8oFVZR5aKh4PU1001ZXPIxEujK5yX/WnrIw5U4weaRcbck4J7npTtpHIHFdDseQ3d3LKXAOTuHHapVnHDKSQaznTnOcVKjAjAOe9ZSproaKZoCbJ54qzDdbeCTisdrsowUqG/nViLDoGGRntWcqdldlqVzdFz8oOVx39adJOp6EVjxsTkE5xVlCcDFY8tii00xwMY+uKjaR244FAIIwRmkZgD83ApbCtcgmjeTIY/L2x1pgiCAEckCrXls2CDxThAMZzT5hH0/LiND821O5PWsRp1Eruy4P8H+NbWpEMSjA4Izn2rk9QylxHGvBdgqjPqa8I97DxT3Oi0ZXm3zuMA8DNaMOTKz44XgUW8YitkRBjNWzF+6wvBqdjKpUu2Up5ldTHnk9qw9et2S/0qOEA53kr65xW+LZftO5R93vVa/geXxBp3zFFjikeRh1wMVvQXvIamovTz/Ii0qIIMqeAOB+NZPikMmqQLJ1MeV9OtbNnJGLYLFwvbJyfzrB8aBV1K2YuQgQElea0jsztwt3iNfM5bxza3MT/ADsGRBywH3u+a4TTo7ldZkhWMFp3CA+w5zmvRfEM0d5GqxsxZ9qZc9veuE8PxqdaupmbLQ5K7ug5Na05aM9KUZSpxUtzba0E+tRW97IIoxneevGOScfSqniXV5ri1TQ9HtlnZ3PlJGnzEdyfbApuuXcZe3itS8t0eDxwXPYe1N1N4PB2lPKrbtdvRl5M8xg9hRGDnJHJj8ZDCwu9X0Xn3OM1y+urdTZ3JBmX5Quf9We9VNL095RuIO3uT3pbC1a8uHuLksRnLN1rbvLiOytCRgADCgd66qk1TXs6e/U83D0p4iX1iv8AJGF4kutkS2VqAAB82Kwbeydh8qk468V2PhTw5N4iu5SHTzBgiNjhpMnovrXaf8Ig+nkfugsicEd/oRQsZHDx5EXUwMcTU55v0R5ta+HLqSyF1tATdtx3zWhbaHmNCsZZ/wCKuxhhltZWjI225P3T2P0qeODy5WIACt6dq56mKnLW56FLCQprRGPpeiJESzptQnAJHStt9JjkjyoGfUVqW8UbDPVf4gKsRQrgcc9iO9cE6jk7nRGOtytoFt+9kXKqwU5LE7a6aGCN9LyMRzRsSFzkA/8A6qxExbXaP/Dnn6VrwyAalcLGVZMbgoHHSnfmiVUTeq6amXcSzrPt8piQOMd6SLUJWVf3DKM43HpW7LG5QTldxDbxnqPcVSu5S5Ec0J2SDeihsYPrWahBrYr2nNsiT7XDJbTRXUaSs20pKCQV9qy9CtfJvLmOMskROSVPO09R+laZk2ypiF4224XKA7vc+tXZ1Q6hFeW6FdoAkiIA7cjH6ilbl1RjJ8qsluekWNjBd6dHHJFAxjOPOJALjGMZ9RxXG6hpjabL+8+65IXnn8q1vDd3AfLkZ8RoBu3g4PPHTOCP6VvX9mjOZlED27/KGPzfTJ7Gu+UFXpKS3R83GrLC1nGWqZ59PA04xt2r/eFUVQWkg3ksuefWu6u4bLZidnSfP30jGMepGefwrnLyz3+ZgF416SBTgj1rhnTcD06OIVRW2En0uK6tnmsWL4G4oeSB7+9cnrGnO0bADHHKnjNdHaNNp8okjJZD1XqDVjUJ7fVCZJQVkGSSeST/AIVCkrX6lRc6UrPVdzzCK2lVxkcZ9KtEOgO11wf0rfuYktVd3TKs3B6gCs2/jXcrKgRSMk5601NTZ2qdzNcsxwGY554pDuKFCCDV0eUrAxqRx3qpqVwIVJTlmHHtW6j0K30MPWnEZWMscdXA/lXO3063V2khQKqcBFHAA6f/AK60tTZt2Dkue1YiRh5SrBlJHODjn0r0aMbIVVcsUkTWvmTTBIgFfpkdOau6pFFDaLAjbvLznA/OtTSrY2umPMbePzpm8tWYZKqPT/GsfVnTEiJyehPrWsdZHl153dl0OelKkBgeM8AdqrTtlsn+I1dZAq5PSsy6k3MSvQdK7qerPGxcuVEjRBkIPQ0+HKYU8qBxSpwAT0Ip+B1HFW30OBIbJg8YOaZbod4OB6GrCKCRmrKQjsDUOpZWNIxK00Cls7eQOuKlt8CNdqkDHerJjPBFMSNgT0rFzurG0Y3HJgkjoRVy2iLHAB4qvHGd+7HPQ1sWJ2nBUZPOaynIrlsNaBI4t7A5ApqCKWNWChs9Kkv2E0kcCHcTywB6CraQrAgVBgAelZX0G48qu9yp5a7NyqcdhioSjb8kEYrSUAg9geKjMPzA44xwajmZJ9CXzZPJHzfyrmvLN/rkLDmK3GW+prW1+VYLeSZzhUU/nWN4eEttE7S5M03zYNeTbS57tPSN0dtb/Nz/AAjgYqyTyBnGOaZYrshQegqR1VnU9zQtjhk7yIeS+QMcd/WsnWtPN3q2ngTMkyiTABxvG0ZBrbXDRuw6g/lXMeKpJftdjh1iUbvmzkt0rel7uptRTlOyNG1QG0j2KNqDBx3xXN+OHX7HFcBSAhO76V0mnEJanaxXHBHrWJ4stlurCVImyGX7vofStIWO3Dy5a9zkpI4by1mcMNoHykdzXn93qH2S/mtrZChbH3u59/auw01zZ6RJCk+8lirKw+YH0FZej6D/AGnrZa42iKH5riQ9FA52/h3raFk3c9HGYlUablc1PDcUejaDca5rI8yVz+4U9N2P4R/M15pPLc+IdWkubhiU3E5NdL4+11ta1CHTNPUx2duNkajsO5PuapQwx2sCwxAEr1I7mt3P2MdPif4HzeEozx1b21XZGdvurSLY0Syw5xlOCB6mqsSvqupRwxhmjU7QRz9TVrW7ryYRbRN++lPQfwiu4+H3hCa3Inmjk8wJkrjoCKxlUUIc7WrPbsk7X0RqaZoFvpiqLaeO4XaG3opUg+hB5BrZiuOqykn3PNWZY4l+VI33L1IHeqzGJxtcYJ9RivNlLnd2dcIaakF9ZxzoWTG6sOSOS15Ksy+46/SuiTZEx8wnZjgjue2azJ/MlDKPuDop5xV0216GsUtmVrWRd5aNsHqVNX4Z1l+XODn06VjpBsuQd7AZ6DrSzzNHcY2ssgPp1qpQT1RbijTupCylHHzjpV3TJAl/HIFIUgA++RWUJonTMm7J6EdqLS7kkuh8jJEp2rmiEbXFH30zvLuRZbcICMhNv/1qqaTBbS30InjEioNxU9AB1J/z2pbWUvZPJtUll+Y46H29KxYrl/O3EnODk+9KOkrnHTotxlBOx09zpVvc3UAsp5pYWXgf3Pb6VIpTTrtzeyzQ3kBAjzFuBGOCQe1YQupJFVPLHyA/MnGRnODVq9upb3yJZGaRI18tCR8wxyVPrirk01zJGLoTuoTlp+P9M0LKZrvUXFikWJMyGN8BQccgZrSDi0dVuY3glYblUHKsD09/51kziK6Ec0RhjkCANsG0dP51ds9QlmjSC7RXUciZfvKR0yayi0r66nNVg2rpadV1/wCCbklzY3ipC6iIgAZJzk46gfnWa9rJARcWkg2k/KGYE/8AAhVhki8kFlLKG4YHlfcVQupZPmzNvz1Yrgke/vTqVFLWW5yUYW0i9PPUyb5nurqXzCkR9EO1fqPer1lZRSRb/ncEfekOap3Cq48t2PltgnPXNX7K7jt49qnco9Tiudu/U76t+Rchlaxp6RW+/wD1iMcYBxmud8SJBbw20Rfc5O/ZjgAV03inX7Sz0vEMcU9xuG1MkbR615XqfiG4muJXnZkkbKBcYAX0qqVGU3dbGmHhUnZyRea78kMCG2hicH+VUmYyK88xyF5wajsVie3ZrkytKR+7weB9ag1OYrCsKhQAcsccn2r0YxWyO+FN31My6fZ5kxYqRwpHrSeHdPW/vkE+7Yo3SP7d6i1NpF+zwHDI43hQOQT0zXQWLRaZpewD/SZjyf7orq2joceJqb23I9av5rsrDb4WCE7I1A28e9cvdZGQTnbkZ962b2TYj72AAGVx3JrCmlzEzNxxmtYqx5U3ZGTqVwM7EGAvFVBCWjBxyTU0MDXV10JA61qQ2rNOkZGCvUV186pRt1PHqQdWd+hFNatHaxnHbIqsox7iuq1qEC02gDKpxXO20e81z0q3NFtk1KfK0PgjB6j8asohUH0qSOMLxjip0QY7c1Eqg4qxWjXjgd6nERIHFTpEBVi0t5JJeQAoPr1qJT7FohsrMtMWI5+lbEdqMAkH6AVYEWFGF5xSCU8jGMCsXO49XqiEQqH3YA4xTZFwcqCR7VJLvaPIGQOtQOZFTjkHile5drkMhIbAJ20MHxuDcVE7sSoZeR2oEqg/e4q7XFytHsvihvtdxZWKn/XyjeM9VHJrQjtxNqyAcJEMmsSGU3fih5V5jtk2A+5rqNHXeZZT1Zv0ryT15PkibSkCJVXqeKHb976YHGKgMjCTgcKKHc7CxOTjFPc5FHUkj5Q8cEdPWuU8ckfZ7SQDpcBAc9ARz+tdVFiOL5ySfSsXxFZQtp4a6fasbZDNk4PXoPy/GuimuxvQko1E2aFkFVFGM7l71R1WKPaTgJu55PBqxpJ863UhtrHkZ7VieLLsWwS1U+Zczn5EHIx3aiN3sXzKnNtvY4XxHZ/ZryaeIyNE7KqeX/yzJYDef1qPx5qEXhTSxo1sp+1MB5pPVm6gH2HU1v8Aie+tfDvhyWO4UNc3KY+bsP73+FeZ+KdTk8Q+II9TuyHb7PFGo9woBJ/Ku6nFL3pHnynUx9RQT0M/TofIiM8rF7mQ5NPvbqOytzNI2XI+77+lPVPkkc/w81zF7M+oXoROUU4AH86UIe1m3L5n0FlhqahBa9DS8E6e2v8Ai2C3u5Fj81iS7Zwte+2ialpk1uZ7h3kVQI3Lbsr6fSvJvDOjXFsBPa4WdU3MCeo6ZBruU1uVobe1uXZ5IhhZDwB6jH+elZYp+0fu9DWhhJpKL173Olu5y9w8k6rHvO4hBgVmXu1huA79RSSXf2i3Ic5OOorNS7baQwOAcZ7V56V2dtGi4/IkcjPDEn24/So5WxnZwe9Ne4i44O6mSys7ZU4A7HvVKJs4XKMsu2UeZxk8UzXJvNvQ0bBgMYIGOMVPK3mfI6DngZ6VU164jt5bW1cIk0S/MQeo6/jW8Y3Fy2aL1gVkAxjcOoNWDFIHZjyxOcgcVk2M6MoeJgV7EVt210BG3OAw2kVmrxZlZqWhv6FDJd2ssMMbtKoLnHQL3rNkQiVkI6HNP0m7mhYiNyFcbWw2M+1OvZttzkfeIxR2JjGSqPsxh3KEYOpVugB5H1q0pDBecc53DrWWhlUMq5JbHAGQamN4qoBwrDripqK2qNJ02y1FeNbPJhd2DwSOM/StW1vYXhh2Iyyj/WfNw/v7Vzr3CEfMQc9fWrFpcIoHPIqLmE6KktdzrIZyo3qxOTxn+tWbiJXAYSKzYzx0rAt76NpTtAWM8Y61p2fkbwHkyG+7z0+tZzj0PNqUnB3K00yLKVlH4jqKivyiWjzXhcMEzHGv3mHqabrXl205JfcpGa47Xr6XaCjMAQT17VNOLm+Q7KNHnSknYxtYvJ7hpbgFUIYDnnntkd+lZ8l4NV1CW5v4/MnMYRXjUKiEe30qOazunlBug0ULKHRTwXB6N9K1oBb/AGKO3iRDKD88i+nYV66SgrI6pRTaaG2caRrlwWjHzFc4yKxNQmBLHHrity8ISMKOfUVhRwm4vhGrYbICr9e9FNdSptQjdi+HLR7i6N5OpeMcKT2NaV24Nw8sgyD0rqrnS/7HsobYyDcV3NgcLnqK5TVirKhUYUHIx/OtOa7PBnPnbaMbUk8/aqng8sfSuf1FyBsTnJwB/KuhucrDuYc4z+Has3Q7E3+r7m5jh+ZvQmtacravocdZtKxoaRpi2lmGkH7xuT9am0+1829Z8clsfgK17pFSMg9Byaj0OFvMDY4ILVzzquV2ZxhZFXXLcmOQf7NcxbxPDKEcc9a9Au7cyK2e5xXOa7a+XIkijvjipoVej6mNaPMilGAecVKsWTzTYsY9xWrpsSu3zDNaSZzohtrYsc44rXt7ZeMDBqaO2T0+lTAFc8ZArPmKsReWccdaY0agZIGfpUruDggcj0qGRmcMT0pXKSGey8HuarsgZjuIx2qwke1O+D69qSUIF+QCkBSeJcc4BqsYuvcGrroDg4IFRFRnAFNSaBnpPhmYCzmn25Mrsc/jiux0pdi4HpmuU0y28jTLWFODwtddakLbl+hPFcC3PSqO5ZBLKw7sadPtVQOck1FaylpTHjAQdalvGA2hRzQjJL3rDs4B7mue8X6l9m0Wa4iYB42D7zyAw56fgK1LucQxEkEgDJrk/ERL+GrtLtwUbDrgc46V1UnrY68PRTak+5qwa7b2ujm/uMfMgYAcZY9gKw7d/syXGu6zgyuMqp/hHZRWH4OtZdfe3a7ONPshiNTwJXHf6CsD4oeJGvboaTpzfu14JHTHc1vRpNuzPNx1ZSn7Ol1OX8Ta3ceItYknkYtArYAzwT2A9hUVuP3KnucgfnVJtlhbqFGWbgCmXN4ttbuc8gYGO5romnPSOx6+DoQwsLS3SuyPXr0QRi1hfLt9856VY8HaeZblZG4AOFPY1zCbriYs5yzGvUvD2nr/AGQmFKkKB/vGtayVGnyLd7jwLeMrOs/hWiOvsIY1t7eVUHyDGMdqoa0iTK0ix7GGdg3dKt6NcAOiyIHjxxHk4+n4Gpbq1WUumBleDXlbM+gpxUJWZm6bdu0RjziQcEetW7B3k3rtJbOCoFZ4tGtSzqfuHOR2FdT4akh8/cyhWfqe1RVjbVF13yRclqZr2LLzJEyg9MinpbLLgFiH6V3NysTxYxnjHrXLapa+VlkHA9ulY81zgp4l1tNmZpsD5yKTvBIFcrqcEtxqspmGEztBIrrkuMK7luUUsPr2rOh2SpkhSGGST61vSlKKudEOZO7OfjU2TFU+53HatWwukbGcc1G6xvLIiqWHY1nyRtbSblBIBzWjtM2cbnURzp5RjwQzHKkHtUlkS08ZlIIVuQf61gw3IZFlZ1zGuNgHJya29NU3Lo6Rs5LbcA8k9iPWly6EpqMWjqRPapHMWgzK4xH5bbQhz3Hf6VyevWcj5eIFduc4rZnV1DbScjtWTJfthklBDcjFZXbd0ZYem4tyic5bzyAsrFiy9zWnaSmSVY5CRnofSqVpE95qrRRlRlSfmOBgc/nWmbUQvtLxsyHG6NtykeoIrWS6mlZ2dluaEUiK3l7iCvBq7bXflTKssp2sPlbr+lZSFZCCuAenFXIo1ddsmQM5Vv7prGSXUxfvR1H6heG4GWfcifxGuS1S48+QjJ2E85PYdq6LVIfLsZ0YYV1IJHTPtXEwFFY+eXdehIPPt1rbDwWrLhtpsSi5mu5Ejcu5X92pJ6L2ArYs4BbxsfTgVDodtE8TmQLuAyCTjPPb1q7cOIcHjg5xWsnfQrbRGZdMXcBcGRjtCd6dpumTrbpey4MsjcKD90A9asywrqM5vJEaDzJBsRR8pHfnrXR3bQLbJFbqAAAoIrSOi0PLxlfVRRh67fyyxrCzZ2DYMd/U1hzF5SGkIVeFCjsK1bwFp84+6MVn3oWOOR8jbGMH3JpN66HntpKxzus3bN+7UD8P0rpvClj9jsF3r+8k+Zj61h6DYf2lqTTOv7tOce/au9EHkRKSMcU6suWPKjkfvSMPVUBhZV6u20VoaVBsBbHGOKo3h8y7Vc8Ic1t2Sj7OhY44zgVyydkW42RE1vvUN6nNZ2oWauBlQdvIrdZCFGOlU503VEXY55HLzWAzuCYJ64qWxi+zviQnb6gc1utGMcrxVaWHk4Fb8z2MGiWKWJ1wknIpxyoOOc+1ZbwsMkDB9aRbiaHAJ3L70xFqUbdoXKknuO1OcLtGBnPWoft6n74INDTrgYwc0wuLISBgYxjHWomHUk07duHTmmvyOSAPXFPQBpkBB3GoSO4xSSKisWAIP6Ux2BALED0qbdEN23PVoSWvI0T+AE1urNlI4uhzzWVo0BM0shHJ4Bq+lvNJdlgjbAMA1556dkakAWNjtGCaW6lKt/eNOhQr1Hao7lepGQKoyj8WpVnPmRsqg7vSuJ8RKNWni0jTQ4n+/eSKeEj44+p6YrpPEmptp9kvkDfeTny4I16sxrKXyfB2iTTXbrLfzEyTSZ+/J6fRa66EW3cWJxXsYcsd2ZfjvXbXwtoIsLFVWQoIwq/wr2X6nvXjykxxyTXJzcznfIx7D0qXU9Rk1zV5L2clolJ2A9z61CsRvbnZgmNT83v7V3tKC5fvDK8K3+/mtXsRRRvMz3U3CAYUHsPWsW8k+0TnHCA4Aro9d3RWflxDCdGb1PoKwLCAzXUajPWroyS95npYuF4qkuu43T7ZkuRvBGORxXq+lXCW1rBbkgBwMH14rMbTStoHt0jMgXblhzj1FWLVXa3gRhhlGM+lY1qntXc7cspxhDkRvRWyqpZM7ux981popSFJAp5YqwP61XtEcIrO4KkcZ7GlTal4XkyYurLnmuSSuepL3tCWe2VlBIDI4P8A9aqOmzm0nMMv3QcZ9K2LYqWKH7j8rntUd9pcmye8+XYmFcDt6E1MXe8WRGqk+SfU3tM1GBI5Y5gXZ1HlNn7pzz+lM1SWN4TkH64rlLe4Krw230Poau2+omZCkhBZevNc84NbHNLBck+eJnXbiCKddpO/7hH8J+neubtppot+8nBPT0rrdRnSGzlchCxU7d4yD2rjWmaIDzBjLZGa6aesdTrp9WbtiQyfMKluoEK5GKp2bm4TcpAIpk4uvNyGTyx1GOTUWuyW7sp3du0RfynZVf7209qv2s8FgY3Wd5mKgM2CNrHniotwf5X/AAqEAiZYiUVSw5bpjNaJ30YPQ7q2lFzbLIjAgjOay9VsZVjFzgBGJUHI5IrP0TU47cfZxKrrnbn/AGvb2rTuCs2Fd9q565rnUXCdmTC8JXWxg2sSrfxl+hYBvpXc6vpMT3N3JY2UkYiIymDypz8/TH5e3vXIamscNy2yZJMdWj6V6dp3ijTtb8ODT/PEN2lssaeYdodlHGG9c4611xSd02cmYVKkHCrTTa6+W3Q8/MB3gR9/StKyGMxygkEcGtWWJUaS7Ept9Rt5A4jlUfvR68ce3HFR3NzDc3ctwkKwLI24RjonsK5asbK6Gq3OrJafr/XUzfF8SWeiI6zpKkq7iO8ZHUGvNF/fyJGrAhjk4rtfGFxvhZFyVRMEY45rmNCt90pmI4FdOH0hc6aEXGGr1Nm2jEdsmM8CqN3LlSpLbz93jrVq8l8uNvf0rJwxB2oZDjJ+bBA9auKu7hUlyq7Oh06B4rDzJipjToM9zS3F0XEccZ4XrWYsrvEFjyQexqWJMEluO1afCrnhVbyk2wlcopOAT1rldbdxHjJ+Y7iPat28ul3SAHheK52If2jrEMI6PIqfhnmop6u5zz91Hc+EdO+y6TbzOuJJf3h+natS6+Y9Sdq5Iq3gRgIAAqAKBVW4/wBRckDOSFA9axlK7uc9OPU5tIXlkd0HDV01vAUUA/d2isy3h2XSodwAPQ10aIGTmsar6FVJFcgBMCqkwB6VosgCAVWeMZ6UoHNJmeBkYzk0yWIcZ71b2BQTUDuCox1rVGbKM8QUY7mq8kS44FWZ3AkyT0qvc3cMK8sC3oKtamcrIpzQd6ryRBQSePekkvnmH7pQoHc1TlkPO58100sPKer0Ry1MTGOi1LBmdOUYY9DSi9fbyBms4uAchuaa0jE12QwtJb6nJPF1HtoWprp26kAe1VGkLHGc0AZ5NHIPAGK64Uox2VjknVlLdn01ZWUVtHtRfxq0y7R8tOVMCoppdoOelfJONj6y7kxY2AJzii6ZWiNYVxqYWfbnip/tgZODUJmzoNWbMXVxGtzHMyAvEcox/hrzD4pXd/fNGoGLM8Eqeg9Pxr0zVnVw3NcDrWCHhk5U+tdNCtKnJNFSwtOtbmPOkjZFWNBhjwB6V0ekac0YhiPyNLyCfTuaradZB753m+YhuAPTsK0btprPUoLiUhQuQRnhR6V3Nuo7I9uEOWPuFLxTBGsBjQDanSsXwrbLLqALD5V610fiMCeLzQPlkGcr0FZPhSAtesA21geD/jSi7QZyrVanoK2u1BsAAINcvqEL2F6rvgRMeQPWu80+LEYDdeuDVXXtOS8tsCP5iO4rCFRJ2ZvQnySTRBpsyLbmO44I9+nvVcuEbzQxYElW/wDrVkWFwVvns7osso+U5BJOOlXZ4sqArEY9Oxq3DU9umlLVdTatZg8aJGwJByp/pWjqu/8As8lI94Y4kReGORx+RpkGiPpkNjdsyzRyoG3Af6tvQ/pV/UXY2kjqCsvPbH4Edqnk5WefUqRlNOnqrnMWlo0n2cZVfMAVt3QGqN3BcWEhlKkR9efQ/wBKsQyt9naCRsuvB9ag1K8aeHymyGKiMbj/AJ4qUnezPQSk35BqF1DdaNAvmhpI3OVJ5APPHtWZc2QuYwfvBRwKmm0uW1V1kZd33SRyAakVPskrQltxUcg9/ce1OTtH3ehi7RjaPUk0RfKQKV2r1q/c+WASxI561mQX6Q3IUnKN09qvCaOTIB78Vg273OezTuULyIouRxWX9p2yEMQSOh7Vp6nIQu1uVPGaxbny1jOSOK6Iam6loQJKBI56EnPy+taV9rc1mIY2BlEg+Vh/I1nxQY2luVNXtbiINufklSIZGRjjGeeh+lW+WT1M3P3lYzbvUruUlYUZdwwSa09HMltGriQ7ieR2NXNPMF3bBk2njkD1qS4txFIoA+U1PMnpY6Ity3Oo0XxDPYyoXhjd1XAWdNwHPUVnaozS6gNTDyF8sRGpwmT14rNKtHGgBOzPB/u0ajcYso1EnCyYdQecdmHvWe+iMXShGXOlqytrU7zSpEcozNyCeo96sQJ9ntgFH1qijPLIHGTycbxlqdqF79njQu4Ef51vayUUaJWVw1Bg5BJwoHJqG2ma0mklTa7v8i5GePWobZZNSTYR8pBY44wKtQW2XQxfKEx8rVpBcurPOxc7+6WVGyZdpy7dcVLeJ+5ZG6Yqq5+z6gjF8gjG3rz60uoXDGMfMMt3rOrLmaseY73uYWpnyogoOGejwZB5niKFiOIULk+9Ub92luCDlscCug8GReVczSDo4wKr4YM5qrvodu8odwec9arRvut3bGCXyM/WmQnB+92IpsY3FFJO0tyK5WSlZEkQMs5difvd62EPygCs5E6nPO7gVoxDKnntWc9WZTYp4Ck9KqyyDcelTPL+7we1Zk86ry2KcEYsJpgEK/nWVNdrCxLd+gqtfXbNIywn6n0rNmJduCWY9zW8IOWxy1a8YadRL2/eRm2/Kv61QzIx3EEL6mrwiEZBbk01lDggDHsa9ClhHuzzquIvuVZJOPT6VWO5+e1WjGMZxtPvTDhO3Peu2NF9TldRLYhEYzkAk04AlueBUgb0oYfrXTGnGJhKbe4wpjvTXOOaey5ppXHWtLO2hnc+qJDxWdeDchA9KtSyY+lZl5OMHBr4hs+2owd9DidYma2vRnoTV+2u/wBznNVfEUXmxlh94cisCLUti7W4YcGhRvsd8pc0UaupXeAeea5PVrhZQeean1G+Dg81zF5eHJGa1pwHBdTW8KxrcajLufa0S7wD3rT16zWeQNKuFLc/lXM+HpGbVlRCQZFK5Haum1aWV0mRsYUYrrjeLPaw8eaNjlrKcGG6sZTlomIGe47GovDgEWpEOcfNmoJpZLS9EgA2S4V8j06fzrTsYVebzVIVgetaT29TjxFH2VR+Z6RYSCR9oUbW5BHer88fAJTA6/UViaRKfLBztZcADtW41yrBQSd3909MVwvRmUNzj/FujLIf7QhEnnRI3CHBPHB/CqWlzNc2IeQAME3EFsHiu1u2WWAoQoUnhu49q8snDaV4hlgJBgkbKjPc11UnzRselhKri+V7HsXhCe4n0mCCBFchxKquOAR1z+VVvE2ovealK9wI4pJFBZY87eBVbwddG2Xy33IM5+oIptxDHcy3NwoIZRjnt61k5WbiznVKMcVKbWn+Zi3tsXCzLgN97j1p1i1rdalbNqOAiyDzjjOB61cMiiPDAZxXN6mfKkyr7WJx+FTGV3Y9KPvJxehueIIoxdTLatvt8ny2xjcO3FcndMSmz5hIp/TtW8t2txp6bOWAwe5zWddR+QUaaL94WPyuMcEcH8DziqpvV3CD5YqL1aOdkZt4BJ3CtnSW3YLE5P6Vn6oiq7EEfLzkUlldeW6bvuk9RVyjdENa2NbWF3AbfrWEtk1zOoJYjritm9nDICORg0mh2Uk7CUvz2BqU+SNx8toEIt5A8ccnCE4z6VPqkiPbh43UDHl7B97d3z7Y71rXlt8q7+MVy+s3b2iqph3xM29eP4h1BPp7VdL3jL2eiaJtBdDO1qyLDKh+WQcBgR0P+Nbtxny1WTqOeaxPBWqs+oXKXUQeOdSACMlDjHH6VtGMLdPlcLjb7VVRam1K97EwGVUAZz2FULyNYEkAjRt524bqvfI9K01t2htxIHVgQThTynPeqLRC5mw7KB/Dj+tYwVmW7MqzWzQxrNt3pGw3BT1rL1K5iOwkFkJxtxnmuzmiSCx2SD5WTkn+dctFZR3l1cQQuDEh4Yjh8c1tTlzMxrVlCDLVliC0ilwMyEjgY4q5ZW5JaR88nH4U77DmeNMbYgO/etGVFjgKp2qq01FWR4cpXMHUrYCbzIydxG3n0rLuW33G3nagzW1eOwQsO449qxHHlJJnJZ+M1jBmE27Gdt+YuR3zXQ+G1eJQW5O01isuWyfu8DFdJZ4ikiHYitJPQ5bXZq2rBifXdjFSW7BJSSRwSar2rKATnktRES05XGeCK53oW0bCANAsgxyc1aRh244qtHFttAoyAKJAqAHceeOtYpnNIhvJhGpyRXN3l150xWIkqDyasarc5lMSZz3PpVBMJEdwwB+tdFKDkcWIrcistyNwd3A+Y9qnhgEa7nI3enpSQr8+9847U+dt/of6V7WFoJLmaPHqzexHKyKCSuKzZpDKx24q264PBJHvTAFHQAGvQtc5m7FUoSo30jIPTPvU0q7j16VHuA654q1Eyb7Ee38qNuKczA9BUbuSPSm+VEpSYMQvNV3Yk8dKc3uaYf0qWaqKPpVpgy9ayr1wASTWNBqxkyASKSe8LDBNfDPU/Q/q7puxS1S54bmuG1ObbMzL1J5rpdSfgnNcdqUygvu61tTQrFW5uiR1rIupMnIp88vX0qn5mSQa74QsrlUnrZm54V51DzCeI1LHPpXUeIblYP3iAMrLg1zfhi0a4troxj51xg5xW4Al1pQMy4li+RgfUVD+I9jDe6k2c5qTrcQrsG0r7Vc0VmARH24AGc1Jc2JKDy1BIY1WhJhmXcvHQkmtXqrIMZKLskdpbEwyKS2VYDHpWvG4kQYGdnf/AGa5e2vSp8ohSp6nPStuG5EYCrkxuOT71yyjY4ErFq6nHKMyBT8oBPWuA8Z26ROty52srYU9Rn0z2rtMJIiNtjY4IBPUVja/apNpssMqqWK5989RiqpO0jVTa2HeG/FVtIys0iW/7sJtI+8QOeTXQ2dy7yO/Jt2GFIHBzXhjQstyjKSEJ5HoRXsemlrWwXe5Y7QQq9elPEU1HVPc66Uo1IvTXYn1UBd2Bjb+tcjq0wDZBIJGCa2r69hMbck555rjtZu1OTmsqSfMdKfKrFiwuJUlBjY4VssAetaXiDUJbwiS5m3mMD5i3I9BVD4fzWlxrMSajE81pu/eojYYj2qbxfbW0mvM5jlt7cykiMjBx2yD3roa98j2l52t03J7LTLvU9Hn1BI1+zxsqMScHnpx6cVjRFEjVUJMvmMrKcfKBXYS+J4NJ8PS2MMiLbTYLrtBZiOnvXmtpd/8TZ59p2OxbHtTp3kmyIzm23Lvp6efzOsilY20tuEUh8ZJGSuOeD2rb0mRYUjDrhG7jsa5dbovOTErMrH+I81qxed5O1s7CcnA5qZwurHTyXR0WoTRyQAIM4rkNatpJmadRshB2qc8ZxXT6BCbq1JUPJhiuCDkcZrC8XJLbmO1zuhZ/MXA5PHIzU0VyvlJVkuVGb4WlXfsfeJdwxgZAHcn9K6iB4rjUEieUEE9QeK4zS5PseoCfIQruHPO044OO9a8N4jvCQpTYeD1B9a2mru6Cm3qjpdXWW3l2pkKy4IrJmjuomR4nBjycqe1bVxJ9sMWwMVYfK7cZHTpUM+nbb4IZT9nKAtz0PesFKzsNSVlcpahqxuNNKMp88fJt9R61d0TT0NpATLhthLDHGaxY7FNUuZXheXyY3xHt4z7mu20uyFvYRszo2SQR3rVtUo6bs8nFVVOXKtkR/Yy2GZu3NVLhFAIzmr17JtQbOAPXvWReSAxFWC7iBXI25anHJuxmakyxtszk9sVlSoSQOvrWjJCCVYnDc5FVpiApO0AdBWsdDmm+hlPzcJF6MCfzroJvklh28Vk20G+580nIJFat6f3sXp0q5PZEW1RftADuB7NnNS2pzcsRnGDUFs+1XJ7jrT7Fwblic4rCbB7M6OA7rUAnnFZutXaw2pYD5iOB71etW/cjIHXt6VzOqTCe8bGTHGcL9azpRc5WOKrNQVykiuE/eEln5Y+lNt/39wVyWiT1705JvMDqp+bOKteSbe33KvzH0r2cNS5n5I8apPe+7GnYykIxGKiKjtihnKqNw5Peot5xXsRVkcMtWKy1EVxnvUhzjIqM+1XFGEnqRMAajYY7VJJjr2qB24qpNImK5iN2AJqu7Z6U+QnJ9KjArOxrsJknrTScmhznpUQY5qrCPV5IvLclTxVWe5Izhqiv7l0LKp6VmSXBMfI5NfEpH6XUb6kt3cEqcniuW1Mgsx7Vo3VyQCKw7qYMTmuinA5JSsZU7fOVP4VXXIfFF2+2TI7VZ0y3fUb+3t4RlpWC1325Y3CDuzuvCVq0ejRzjgmTcR6jpTdRcQaxPAjKFmXccetdyNPj0+2hihj3Kihcep715x4sAtdfEqZA4JB+vNcVOXPJnsYSak7E9rM0crxEA5wf0rP1X5CeOvf0qzAyrdb2B+ccGqmrvvz/dFdEdyMUuZhp16skQdsb04Irdt77MihThW9TXBQM0d2wX7jLmtG1uCrcHPGOTVTpnNCSnp1R3kr7FIyVc87s8GmSyCS0SOTqMHp37/pWTYXXmw+S5BG3rSCR4X2SOShPB64rBQC72ZneJLK3hlSW3iXG4Mw3c/nXQWOq2t0iXCDG5McHr+FZepzh1dUjV4WGGxz+lcd9pfRrjaFkw5yB2H0rR0/ax80XSq+zfvbM6jU7t/MZgNsXIGeprmrqXzC/rT5Li5uEBdW2np71SaFi/vVU4KJ2uonojb0LXI9JtTbvbLIS29ZF4YH3o1vWBqcgf5i5/Gi20Oc2cc88Lokq7kZh1A4yKsaNot5cyTC3gklMQ3ExjJx603yc1+pVJqJWt9KFzNCrktvIB+b/Go5NMWK52RsSc+nSugFltYRlSjDqCMEUj28dsC+7e3Oah1Gjd0+pHp1oRIqvtUH+Ij07V0EJWSMoxXOMHPSufjuAbmCIyfu9wI5wBmt7TfLBePKswJz3yKxm3a5ottS94cDR35hZ/LiKkhk6ZHeq/i+Am1WcIf3OWU55x3GK0LWV7Ql7WKORzgoWj3fgKoa7qL363LJGgLZ3RhdoUn27Uk23dGfK3Uv0sebXLlogyg5JD/hXR6SxuLGKRpYlDAggcsOepHbOePpXPQwsiP5gCmM4Zd3J+gqz4fujJLJFEpDbvlTrwe1dcldaEKSTOo1WZ7eNY4pi2zDJJtw1Lbx3N7bktcP5c7bXZTzxjgjsOaztTlAmjUZU/dcP/Ce9dD4djWFQo3OWIbn+lSo6XYYqqo0uVbs17O1W2LG0iAjXKKD3q3JEVRCcqx6gGpUKrGhUjcT696bOx3AuTgda4qs3N3PHtYo3bKwC5yQayJ5UZicFiT09KuX8oUHZyetYjyFzkjAHNKKIauS3Mo3lUxuPFZ9zzlSOlWrWPzN7v8ALj7oNCW4mZsdOtarRmDikyOwhClFyc8Zqa5ObnbjgGrdnbAF2PXFV51ImHOelF7sya1J7fJRw2OnaixOLxlPI7CpbVNxJ/CoLbjUFGeorOexL2ZqSz+TpzkE7ycCsJA3mAKfc/Wr1yTLKRkbV7VTBCEjac9MitcNBrU8XFT5pcq6C28Ia45TGOTirM7h/lHAHrU8MW2PG47iOTVeRJPNxkEV9FhqPs4a9Tx6tTmlYpyM2OxqNOeSKluAV/hxz2poHtiuh9iI7XE4x6VC5xyKmkIHWqkkmTgdKu9lYwS5ncYzZPFV5Dg9akdsZqu5zyam3ctO+w1jzTWNBOB71GWNNIlsRj1qInmns3FQtnNEmVTPQ53V52IOR6VSuQMcVr3FmiMWHWsi6O3Ir4pH6BVrJ7GHeN1BNc3dTFZCCa2tUl2Ma527bc2RXoUIdznlK6IJ23816V8H9CaW4bVJ1+RPljz3PrXn+i6fJqupwWcIy0jAH2FfS2iabDpWlw2cKgKi44HeljKijH2aLpPTmZFfIGjJPBHNePfEVGa/WaPJRRsbjvXsmpLwBngiuB8S2i3sN3F+727cfN13e1cdCXLK56WDnyyucPp18RCIZSAxHy56g0PIs8RwSXHysMY5rnFdlvVhuZGRQ+1mxuI98d61dOuTLbk8HacZxyw7GvQcLanXiLatEDjy7qIngE7TUVw721wRgheoNWtQVguVAJBzRqGy4jhlUffWto2tqeLUlKEuZD9OvT5m7dgVsrO0kbHPHrXErIYJmQ8EdPetvS7/AHEpISDjp2NROm1qjphWjUV0WJJmim3wO0bkYx6//WqlrirLbxSthXV+hHU1fuIxcDczYI6etVZ4JLi2IkYgduKUXZmslGcdBsF6skKqoDMo6Cuh0Sy0yGwa41FpPtrPlEKjZsx1z657VxumW10NZ8i1TzHk6D2r0S40yI6VJDfM0V7Hg7cjgAdDWVaKjonub0bTVuo/UfEsWoQWsBGI7aBYFUDoo/8A11reDtTh03TLm5tZWFxI+wx5+Xbjr6g15o8bq5AJGe4pvm3EAJhdl4wfeo9l2Z1OhDl5LaHWWs8ZvP3shLOTlietW9UlhjtXbrx3rz0HU7py8Kv5aMAXVeAfSrE6ajP+7mZgFOCvIolQ1u2aOqm7oJ7sy3ZCfKCeldv4KhmuHW3WdIElO2SVwSAOuSBzXHWWlTvIpx0P516J4a06WxEFwy4Qttwe5xTqyjayB1NGr6mrqFvJYMU84F4/ushyp+hrkPELXUNu0lvnMrbN3BJyfSvY3uLJrNhcLbLE0BTeecuOc/71eV+OhbzW08yIsMe3AhX7uKxhZNXMcNiZ1YuPLZ9zzfWrS7sbS1uZ4/LiuAdmWyxPqR1GQRT9CFzNfxNaQ7pVAZ1bow9/arvhjw7ca00Qu4pI7aIl/NZT84I4UZ9K6200uCznks7F3fef9ImY5Y/7OfSu6c18K3OPCus489V6DLS2k1C3SW5ZWTcSEQYAwcD8K6q2tUhaIKpBRRk56mo9KSCCVI2RBAoI2gcHH9a0J3VpAIVPPPNc1Wo0uVClJyepDGFEj7j83UD0ptw5cP1wByaJ1JPmR8EdT606EKykt3NcdmRN9TGu0JyW6YxVF4QCSAcVt3hAfAxwOKp5Gw5HPWtYmUpMzJ22siopBf1rStYQkYGO2SajjszI3nPng1aGVjfbmm3YjlVgHAGMdDms9sC5Bbpg1eOViJ71VvY8vBsPJOfqKmO5nJaFm3jxuOOQQapTYhu1f1zV7O0tjhcVQmCtcAZHHahq5zVJckXIliXMRLDOeajhBkuAFI2KcmnvgRsVIx6VJpqbYi5Xlq9TD0+aSR81UlvJlkg4OCKrSqeWIB+lWWA67TVO8lKREjivc2R51m2ZV/JhlAB5NPV/lGKryu0p+eMg9jTDNsTbjmsk7u51SjaFh1xJk4NQE56UoJIyeaQ4x71pFdTlm7aEb98VXlbtUjketQsCWz2pvUS0Q1unIqJulStn1qJ85qrEjQaY+c0/OOopkmDzUtGkNz1K+chTXOXzHBoor4uO59p0OV1YkgmsOQ5zRRXqUNhdD0H4KWsU2tyzSLl41+X2r2u6+XOOKKK87F/xWbw2RSuAHjy3JrjNVjTeflGSck4oorKnudlA8X8RHbqlwV4IZv51asjs09CuMkCiivYXwo7K3+Rfuv8AUbu+Ko2kjNpeTjKMQPzoopxPMqbGVrQzI7dCOmPpTNJmeRELHJ6Zoorra/dHl0m1ibLsbsMr4IzVlHZyNxoorhZ7kDqPh5tt/FcVysaNIiEjeMj8qXxoB/aBlACu33scZoorkm/3pthNK/yMGZFwCBUaopUZGfrRRWkdj14m9pGbTRo2tiY2e7MbEfxLtBwfxptxAqXFzklzuzubrk0UVEzGyu/UuWCqpXAFdDFqE8mn3KHaFTCqAOmOf50UVzPchpOWv9amBq+o3Cg4YfMea0vCZW6a6+0RpIY9uwsudv0oorZ7I68SrUtCt4mvLi3eNIJWjVmKHbxxgGrXh63ijtEIQE9cnqc0UV07Uro4MRsjUt4U+fj+KpnUByQOgNFFccjlItgaFM0rqEHyjpRRRExluZRPm3oV+hbBqtMok1IoeFB4Aooq4i+0atwgSMIvAqtMAqcCiis5ELZDHUFearSoDPCD60UVMdzOexZkAywHQCucd2/tkAEgUUV0U/iOHFfwmas7ZXnHYVPOBGiqvAAoor2MJ8TPmp7CMSIlwTVW5JZgD0oor0OhzS3Kc44bHasmTiQ0UUupvH4SQHCikzng0UVpHY46nxFWYfNUR4FFFNh0QEcVC1FFUSNJ60xulFFRI0juf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dissection is being taken down the deep fascia of the medial thigh. Vulvar specimen is being retracted to the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of C. William Helm, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3555=[""].join("\n");
var outline_f3_30_3555=null;
var title_f3_30_3556="Prednicarbate: Patient drug information";
var content_f3_30_3556=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Prednicarbate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/31/6644?source=see_link\">",
"     see \"Prednicarbate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7796?source=see_link\">",
"     see \"Prednicarbate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F212804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dermatop&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F212805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dermatop&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin rashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702785",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to prednicarbate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696929",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use on the face, underarms, or groin unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3002975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug with latex products. The latex products will not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11838 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-ACA0B7D5D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3556=[""].join("\n");
var outline_f3_30_3556=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212804\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212805\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013581\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013580\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013585\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013586\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013588\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013583\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013584\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013589\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013590\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/31/6644?source=related_link\">",
"      Prednicarbate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7796?source=related_link\">",
"      Prednicarbate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_30_3557="Fibrovascular polyp intraop";
var content_f3_30_3557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophageal fibrovascular polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intraoperative view of an esophageal fibrovascular polyp before resection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Amy Lo, MD, Daniel Wild, MD, and Moises Guelrud, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3557=[""].join("\n");
var outline_f3_30_3557=null;
var title_f3_30_3558="Gas gangrene in muscle";
var content_f3_30_3558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrotic muscle with clostridial gas gangrene",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hematoxylin and eosin-stained biopsy of muscle (x400) from a patient with clostridial gas gangrene shows extensive necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Calderwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3558=[""].join("\n");
var outline_f3_30_3558=null;
var title_f3_30_3559="Xerocytosis";
var content_f3_30_3559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F62761&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F62761&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Xerocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral smear from a patient with hereditary xerocytosis shows many hyperchromic red cells with hemoglogin puddled at the periphery of the cell (eccentrocytes, arrows). There is also marked anisocytosis, poikilocytosis, and target cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carlo Brugnara, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3559=[""].join("\n");
var outline_f3_30_3559=null;
var title_f3_30_3560="Butalbital, acetaminophen, caffeine, and codeine: Drug information";
var content_f3_30_3560=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Butalbital, acetaminophen, caffeine, and codeine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?20/45/21205?source=see_link\">",
"    see \"Butalbital, acetaminophen, caffeine, and codeine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F14854546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Warns of Codeine Use in Children After Tonsillectomy and/or Adenoidectomy",
"     </span>",
"     <span class=\"collapsible-date\">",
"      August 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA has issued a Drug Safety Communication after reviewing reports of children who developed serious adverse effects, including death, after receiving codeine in the usual dosage range for pain relief following tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome. Three deaths occurred in children that had evidence of a genetic variation (&ldquo;ultrarapid metabolizers&rdquo;) which results in faster and more complete conversion of codeine to morphine, possibly leading to overdose or death. The estimated incidence of this genetic variation is ~1-7 per 100 people, but may be higher in some ethnic groups.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Healthcare professionals should be aware of the risks associated with the administration of codeine or codeine-containing drugs in children after tonsillectomy and/or adenoidectomy for obstructive sleep apnea and should use the lowest effective dose for the least amount of time on an as-needed basis. Parents and caregivers who observe signs of overdose in a child such as unusual sleepiness, confusion, or difficult or noisy breathing should stop codeine administration and seek medical attention immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#",
"       </a>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F13114312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fioricet&reg; with Codeine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F143600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic Combination (Opioid);",
"     </li>",
"     <li>",
"      Barbiturate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F143588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Adults: 1-2 capsules every 4 hours. Total daily dosage should not exceed 6 capsules.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F143589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustments recommended. Use with caution due to increased risk of adverse effects.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F143590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustments recommended; use with caution. Limited, low-dose therapy usually well tolerated in hepatic disease/cirrhosis. However, cases of hepatotoxicity at daily acetaminophen dosages &lt;4 g/day have been reported.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F143572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: Butalbital 50 mg, acetaminophen 325 mg, caffeine 40 mg, and codeine phosphate 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fioricet&reg; with Codeine: Butalbital 50 mg, acetaminophen 325 mg, caffeine 40 mg, and codeine phosphate 30 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F143557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F143601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F143573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of symptoms of complex tension (muscle contraction) headache",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F143607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Fioricet&reg; may be confused with Fiorinal&reg;, Florinef&reg;, Lorcet&reg;, Percocet&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Phrenilin may be confused with Phenergan&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Duplicate therapy issues: This product contains acetaminophen, which may be a component of other combination products. Do not exceed the maximum recommended daily dose of acetaminophen.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F143598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, depression, dizziness, drowsiness, euphoria, excitement, fatigue, fever, headache, high energy, intoxicated feeling, lightheadedness, mental confusion, sedation, seizure, sluggishness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Hyperhidrosis, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hot flashes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, dysphagia, flatulence, heartburn, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Leg pain, muscle fatigue, numbness, paresthesia, shaky feeling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Heavy eyelids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Earache, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Diuresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Potential reactions associated with components of Fioricet&reg; with Codeine include agranulocytosis, cardiac stimulation, dependence, erythema multiforme, hyperglycemia, irritability, nephrotoxicity, rash, thrombocytopenia, toxic epidermal necrolysis, tremor",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F143575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to butalbital, codeine, caffeine, acetaminophen, or any component of the formulation; porphyria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F143561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity:",
"     <b>",
"      [U.S. Boxed Warning]: Acetaminophen may cause severe hepatotoxicity, potentially requiring liver transplant or resulting in death; hepatotoxicity is usually associated with excessive acetaminophen intake (&gt;4 g/day).",
"     </b>",
"     Risk is increased with alcohol use, pre-existing liver disease, and intake of more than one source of acetaminophen-containing medications. Chronic daily dosing in adults has also resulted in liver damage in some patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity/anaphylactic reactions: Hypersensitivity and anaphylactic reactions have been reported with acetaminophen use; discontinue immediately if symptoms of allergic or hypersensitivity reactions occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenanthrene hypersensitivity: Use with caution in patients with hypersensitivity reactions to other phenanthrene-derivative opioid agonists (hydrocodone, hydromorphone, levorphanol, oxycodone, oxymorphone).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol use: Use with caution in patients with alcoholic liver disease; consuming &ge;3 alcoholic drinks/day may increase the risk of liver damage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; G6PD deficiency: Use with caution in patients with known G6PD deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CYP2D6 &ldquo;ultrarapid metabolizers&rdquo;: Use caution in patients with two or more copies of the variant CYP2D6*2 allele; may have extensive conversion from codeine to morphine and thus increased opioid-mediated effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects. Decrease initial dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Caffeine: May cause CNS and cardiovascular stimulation, as well as GI irritation in high doses. Use with caution in patients with a history of peptic ulcer or GERD; avoid in patients with symptomatic cardiac arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dosage limit: Limit acetaminophen dose from all sources (prescription and OTC) to &lt;4 g/day.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F143596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F143565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Barbiturates may increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adenosine: Caffeine may diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Barbiturates may decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Busulfan: Acetaminophen may increase the serum concentration of Busulfan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Barbiturates may increase the metabolism of Calcium Channel Blockers.  Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: Barbiturates may increase the metabolism of Chloramphenicol. Chloramphenicol may decrease the metabolism of Barbiturates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholestyramine Resin: May decrease the absorption of Acetaminophen. Effect is minimal if cholestyramine is administered 1 hour after acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Barbiturates may diminish the therapeutic effect of Contraceptives (Estrogens). Contraceptive failure is possible.  Management: Use of a non-hormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Barbiturates may diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.  Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Barbiturates may decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Barbiturates may increase the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Acetaminophen may enhance the hepatotoxic effect of Dasatinib. Dasatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Barbiturates may increase the metabolism of Disopyramide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Doxycycline: Barbiturates may decrease the serum concentration of Doxycycline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide: Barbiturates may decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide Phosphate: Barbiturates may decrease the serum concentration of Etoposide Phosphate. Barbiturates may increase the metabolism, via CYP isoenzymes, of etoposide phosphate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: Barbiturates may decrease the serum concentration of Felbamate. Felbamate may increase the serum concentration of Barbiturates.  Management: Monitor for elevated barbiturate concentrations/toxicity if felbamate is initiated/dose increased, or reduced concentrations/effects if felbamate is discontinued/dose decreased. Refer to phenobarbital dosing guidelines for patients receiving that agent.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Formoterol: Caffeine may enhance the adverse/toxic effect of Formoterol. Caffeine may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Barbiturates may enhance the CNS depressant effect of Fosphenytoin. Barbiturates may decrease the serum concentration of Fosphenytoin. Fosphenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: Barbiturates may decrease the serum concentration of Griseofulvin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of Barbiturates. Management: Consider a decrease in the barbiturate dose, as appropriate, when used together with hydroxyzine.  With concurrent use, monitor patients closely for excessive response to the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imatinib: Acetaminophen may enhance the hepatotoxic effect of Imatinib. Imatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indacaterol: Caffeine may enhance the adverse/toxic effect of Indacaterol. Caffeine may enhance the hypokalemic effect of Indacaterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May enhance the adverse/toxic effect of Acetaminophen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: Barbiturates may decrease the serum concentration of LamoTRIgine.  Management: See lamotrigine prescribing information for specific age-dependent dosing guidelines regarding concurrent use with a barbiturate, as well as for adjusting lamotrigine dosing if concurrent barbiturate therapy is discontinued.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meperidine: Barbiturates may enhance the CNS depressant effect of Meperidine. Barbiturates may increase serum concentrations of the active metabolite(s) of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Barbiturates may enhance the CNS depressant effect of Methadone. Barbiturates may decrease the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrapone: May increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Acetaminophen may enhance the hepatotoxic effect of Mipomersen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May enhance the CNS depressant effect of Barbiturates. Barbiturates may decrease the serum concentration of Phenytoin. Phenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: May enhance the adverse/toxic effect of Barbiturates. Primidone is converted to phenobarbital, and thus becomes additive with existing barbiturate therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Acetaminophen. Probenecid may also limit the formation of at least one major non-toxic metabolite, possibly increasing the potential for formation of the toxic NAPQI metabolite.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Barbiturates may decrease the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyridoxine: May increase the metabolism of Barbiturates. Apparent in high pyridoxine doses (eg, 200 mg/day)",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Barbiturates may enhance the hepatotoxic effect of QuiNIDine. Barbiturates may decrease the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May decrease the metabolism of Caffeine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Gemifloxacin; Levofloxacin (Systemic); Lomefloxacin; Moxifloxacin (Systemic); Nalidixic Acid; Ofloxacin (Systemic); Sparfloxacin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regadenoson: Caffeine may diminish the vasodilatory effect of Regadenoson.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatostatin Analogs: May decrease the metabolism of Codeine. The formation of two major codeine metabolites (morphine and norcodeine) may be impaired by somatostatin analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: Acetaminophen may enhance the hepatotoxic effect of SORAfenib. SORAfenib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teniposide: Barbiturates may decrease the serum concentration of Teniposide.  Management: Consider alternatives to combined treatment with barbiturates and teniposide due to the potential for decreased teniposide concentrations.  If the combination cannot be avoided, monitor teniposide response closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teriflunomide: May decrease the serum concentration of Caffeine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Barbiturates may decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Barbiturates may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Barbiturates may increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Barbiturates may increase the metabolism of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Acetaminophen may enhance the anticoagulant effect of Vitamin K Antagonists. Most likely with daily acetaminophen doses &gt;1.3 g for &gt;1 week.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Barbiturates may decrease the serum concentration of Voriconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F143581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: Avoid ethanol (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F143568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F143577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination. Withdrawal seizures were reported in an infant 2 days after birth following maternal use of a butalbital product during the last 2 months of pregnancy; butalbital was detected in the newborns serum. Also refer to individual monographs for information specific to acetaminophen, caffeine, or codeine.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F143592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F143578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Barbiturates, acetaminophen, caffeine, and codeine are excreted in breast milk. Also refer to individual agents for information specific to acetaminophen, caffeine, or codeine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Butalbital-APAP-Caff-Cod Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-325-40-30 mg (100): $149.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Fioricet/Codeine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-325-40-30 mg (100): $547.94",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F5996303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hepatic and renal function tests (in patients with impairment)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F143560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Combination product for the treatment of tension headache. Contains codeine (narcotic analgesic), butalbital (barbiturate), caffeine (CNS stimulant), and acetaminophen (nonopiate, nonsalicylate analgesic).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Antlitz AM, Mead JA Jr, and Tolentino MA, &ldquo;Potentiation of Oral Anticoagulant Therapy by Acetaminophen,&rdquo;",
"      <i>",
"       Curr Ther Res Clin Exp",
"      </i>",
"      , 1968, 10(10):501-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/4971464/pubmed\" id=\"4971464\" target=\"_blank\">",
"        4971464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bagheri H, Bernhard NB, and Montastruc JL, &ldquo;Potentiation of the Acenocoumarol Anticoagulant Effect by Acetaminophen,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1999, 33(4):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/10332548/pubmed\" id=\"10332548\" target=\"_blank\">",
"        10332548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bartle WR and Blakely JA, &ldquo;Potentiation of Warfarin Anticoagulation by Acetaminophen,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 265(10):1260.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/1995971/pubmed\" id=\"1995971\" target=\"_blank\">",
"        1995971",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boeijinga JJ, Boerstra EE, Ris P, et al, &ldquo;Interaction Between Paracetamol and Coumarin Anticoagulants,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 1(8270):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/6121161/pubmed\" id=\"6121161\" target=\"_blank\">",
"        6121161",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gadisseur AP, Van Der Meer FJ, and Rosendaal FR, &ldquo;Sustained Intake of Paracetamol (Acetaminophen) During Oral Anticoagulant Therapy With Coumarins Does Not Cause Clinically Important INR Changes: A Randomized Double-Blind Clinical Trial,&rdquo;",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2003, 1(4):714-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/12871405/pubmed\" id=\"12871405\" target=\"_blank\">",
"        12871405",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gebauer MG, Nyfort-Hansen K, Henschke PJ, et al, &ldquo;Warfarin and Acetaminophen Interaction,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2003, 23(1):109-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/12523469/pubmed\" id=\"12523469\" target=\"_blank\">",
"        12523469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hylek EM, Heiman H, Skates SJ, et al, &ldquo;Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1998, 279(9):657-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/9496982/pubmed\" id=\"9496982\" target=\"_blank\">",
"        9496982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kwan D, Bartle WR, and Walker SE, &ldquo;The Effects of Acute and Chronic Acetaminophen Dosing on the Pharmacodynamics and Pharmacokinetics of (R)- and (S)-Warfarin,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1995, 57:212.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rubin RN, Mentzer RL, and Budzynski AZ, &ldquo;Potentiation of Anticoagulant Effect of Warfarin by Acetaminophen (Tylenol&reg;),&rdquo;",
"      <i>",
"       Clin Res",
"      </i>",
"      , 1984, 32:698a.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Bemt PM, Geven LM, Kuitert NA, et al, &ldquo;The Potential Interaction Between Oral Anticoagulants and Acetaminophen in Everyday Practice,&rdquo;",
"      <i>",
"       Pharm World Sci",
"      </i>",
"      , 2002, 24(5):201-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/30/3560/abstract-text/12426965/pubmed\" id=\"12426965\" target=\"_blank\">",
"        12426965",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8702 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-E8E148C781-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3560=[""].join("\n");
var outline_f3_30_3560=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14854546\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13114312\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143585\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143600\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143588\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143589\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682368\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143590\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143572\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143557\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143601\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143573\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143607\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143598\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143575\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143561\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143596\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143565\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143581\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143568\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143577\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143592\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143578\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422204\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5996303\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143560\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8702\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8702|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/45/21205?source=related_link\">",
"      Butalbital, acetaminophen, caffeine, and codeine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_30_3561="Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract";
var content_f3_30_3561=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Maurits J Wiersema, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Ian D Norton, MBBS, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3561/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/30/3561/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H109379500\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasonography (EUS) has evolved from a diagnostic imaging modality to one that can also be used for invasive diagnostic and therapeutic procedures. These advances are largely due to the introduction of linear scanning instruments that can be used to place devices into the ultrasound plane of view, permitting various interventions to be performed. The ability of EUS to guide a biopsy needle into lesions that are too small to be identified by CT or MRI or too well encased by surrounding vascular structures to allow percutaneous biopsy secures its role in a variety of clinical settings.",
"   </p>",
"   <p>",
"    Indications for EUS-guided fine-needle aspiration (EUS FNA) include biopsy of mucosal and submucosal lesions in which prior conventional endoscopic biopsies have been nondiagnostic. The procedure is most commonly used to sample peri-intestinal structures such as lymph nodes and masses in the pancreas, liver, adrenal gland, and bile duct. It has also been used to aspirate peritoneal and pleural fluid.",
"   </p>",
"   <p>",
"    This topic review will summarize experience with EUS FNA in the gastrointestinal tract. A discussion on EUS guided trucut biopsy is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"     \"Endoscopic ultrasound guided trucut biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379195\">",
"    <span class=\"h1\">",
"     EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of different endoscopic ultrasound (EUS) devices are available. Most are similar to standard endoscopic instruments in that they have biopsy channels and video or fiberoptic endoscopic capability. They differ from normal endoscopes by having sophisticated ultrasound transmission and reception capability at the tip of the instrument.",
"   </p>",
"   <p>",
"    \"Linear\" instruments scan in the same plane as the long axis of the endoscope, whereas mechanical \"radial\" instruments have a rotating mechanical ultrasound probe that scans in a circle at 90&deg; to the long axis of the endoscope. The ultrasound signal is then integrated by a complex processor and transmitted in real-time to a video screen. Until recently, electronic (linear) and mechanical (radial) EUS instruments required separate processors, adding significantly to the cost of providing a comprehensive EUS service. However, 360 degree, electronic radial echoendoscopes have been developed, allowing for use of a curvilinear array and a radial echoendoscope by a single processor thus economizing EUS service.",
"   </p>",
"   <p>",
"    The electronic curved linear array echoendoscope is optimal for performing EUS-guided fine-needle aspiration (EUS FNA) since it permits real-time visualization of the needle as it is advanced into the periluminal space (",
"    <a class=\"graphic graphic_table graphicRef54912 \" href=\"UTD.htm?8/32/8716\">",
"     table 1",
"    </a>",
"    ).",
"    <strong>",
"    </strong>",
"    This instrument has an electronic ultrasound array that scans in the long axis of the endoscope, in line with the viewing and biopsy channels. As a result, a needle advanced through the biopsy channel into the tissue of interest is in the plane of ultrasound and thus visible in the ultrasound image in real-time as the biopsy is performed (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68097 \" href=\"UTD.htm?34/60/35778\">",
"     image 1",
"    </a>",
"    ). EUS FNA has also been described using a radial scanning instrument. However, with this instrument the needle cannot be visualized during its entire course, and serious complications have been described. Thus, this technique is",
"    <strong>",
"     not",
"    </strong>",
"    recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several needles are available for performing EUS FNA (Cook Endoscopy Inc, Winston-Salem, NC; GIP Mediglobe, Tempe, AZ; Olympus Inc, Center Valley, PA; Boston Scientific, Natick, MA), each of which uses a wire spiraled protective catheter assembly with an attached handle mechanism that secures to the Luer lock adaptor on the echoendoscope. Needles range from 19 to 25 gauge with a depth of penetration of up to 10 cm. There is no evidence that larger bore needles provide greater diagnostic accuracy. All needles have a central stylet beveled to match the needle tip, thereby enhancing the sharpness of the device. The 19 gauge needle is quite stiff and can be difficult to manipulate in the duodenum with a sharply curved instrument.",
"   </p>",
"   <p>",
"    Needles have also been developed to obtain core biopsies. One 19 gauge needle (EchoTip ProCore needle, Cook Endoscopy) was used in a study of 109 patients with 114 intraintestinal or extraintestinal mass lesions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peri-intestinal lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/2\">",
"     2",
"    </a>",
"    ]. Fine-needle biopsy (FNB) was technically successful in 112 lesions (98 percent), with a sensitivity of 90 percent and a specificity of 100 percent for malignancy.",
"   </p>",
"   <p>",
"    Two manufacturers have introduced needles with side holes in the hope that with suction, tissue will prolapse into the needle from the side and then be cleaved off as the needle moves back and forth. Prospective comparative studies with these needles are not yet available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379202\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The site selected for endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) should represent that which would provide the most advanced stage disease if malignancy is identified (eg, perigastric as opposed to paraesophageal lymph nodes in a patient with primary esophageal carcinoma) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61998 \" href=\"UTD.htm?17/18/17704\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link\">",
"     \"Diagnosis and staging of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The needle catheter assembly should be advanced through the endoscope (the elevator should be down or relaxed) and secured to the Luer lock adaptor. Some degree of balloon insufflation is necessary to allow acoustic coupling. However, care should be taken to prevent puncturing the balloon with the needle tip. The risk of balloon puncture can be reduced by applying luminal pressure with the",
"    <span class=\"nowrap\">",
"     up/down",
"    </span>",
"    ratchet.",
"   </p>",
"   <p>",
"    The needle should be advanced into the target lesion under direct EUS guidance. Prior to advancing the needle, flow Doppler imaging should be obtained to avoid intervening blood vessels. A swift jabbing motion is occasionally necessary to traverse the muscularis propria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    enter the lesion. When the needle has entered the lesion of interest, the stylet is removed and negative pressure is applied with a 10 mL syringe. Prior to removing the needle, the negative pressure should be released (this should be done just by releasing the syringe plunger and not forcing it back to its neutral position). Reduced negative pressure (1 to 2 mL) may result in less bloody aspirates, particularly with vascular tumors (eg, neuroendocrine) or lymph nodes. One study suggested that when biopsying lymph nodes the cellularity was increased with suction, but this did not improve the likelihood of a correct diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/3\">",
"     3",
"    </a>",
"    ]. The location of the aspiration within the lymph node (eg, edge or center) did not influence the accuracy of the findings.",
"   </p>",
"   <p>",
"    The optimal number of aspirates that should be obtained to maximize the chance of achieving a correct diagnosis is uncertain. A prospective study involving 95 patients with a variety of lesions estimated that at least seven passes were required for pancreatic and other miscellaneous lesions, while five appeared to be sufficient for lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The aspirated material should be prepared by spraying it onto glass slides, which have been labeled with the patient's identification. One slide should be air-dried for on-site interpretation and the other slide should be spray fixed. In patients in whom lymphoma is in the differential diagnosis, additional material should be collected in a preservative solution that permits flow cytometry if desired. In patients in whom an infectious etiology is suspected (eg, mediastinal lymphadenopathy), culture media can be used.",
"   </p>",
"   <p>",
"    After the material has been sprayed onto the glass slides, a saline wash should be performed through the needle and the material should also be collected to be made into a cell block. The stylet should be then wiped off to remove any remaining blood and the needle purged of any remaining fluid using air. The entire needle device can then be reassembled for further use. Ideally, a cytotechnologist or cytopathologist is present during the procedure to examine the slides, indicating when a representative cellular sample has been obtained. If this is not possible, three passes should be taken through lymph nodes and five to six passes through pancreatic masses to ensure adequate cellularity in &gt;90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379209\">",
"    <span class=\"h2\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for antibiotic prophylaxis for EUS FNA of lesions in the GI tract are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=see_link\">",
"     \"Antibiotic prophylaxis for gastrointestinal endoscopic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379216\">",
"    <span class=\"h1\">",
"     TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquiring the necessary skills for performing endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) depends upon a fundamental understanding of normal and abnormal EUS anatomy to avoid inadvertent sampling of structures that should not be biopsied (eg, right kidney confused for a pancreatic head mass or splenic artery aneurysm mistaken for a pancreatic cyst).",
"   </p>",
"   <p>",
"    The American Society for Gastrointestinal Endoscopy (ASGE) has developed guidelines for formal training of individuals to achieve competence in performing EUS examinations, which should also permit adequate exposure to learn FNA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/6\">",
"     6",
"    </a>",
"    ]. However, for those in whom standard EUS training has not provided the opportunity to learn FNA, a reasonable option is to attend a course and (optimally) participate in a live animal teaching class to obtain familiarity with the equipment and maneuvering of the needle device.",
"   </p>",
"   <p>",
"    Training should begin with relatively easily accessible lesions (such as paraesophageal or perigastric lymph nodes) followed by more difficult lesions (such as those arising from the pancreas) once a sufficient degree of comfort has been obtained. Assistance from a radiology colleague who has interventional experience can be helpful.",
"   </p>",
"   <p>",
"    The ASGE has also developed guidelines for credentialing and granting privileges for endoscopic ultrasound, recognizing the varying degrees of difficulty and technical skills required for EUS of the gastrointestinal tract (ie, pancreaticobiliary versus mucosal tumors). These guidelines represent a minimum number of procedures necessary to gauge competency and may serve as a resource for practitioners interested in acquiring these skills [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379223\">",
"    <span class=\"h1\">",
"     PANCREATIC MASSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of pancreatic masses is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1929?source=see_link\">",
"     \"Endoscopic ultrasound in the staging of exocrine pancreatic cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379230\">",
"    <span class=\"h1\">",
"     PANCREATIC NEUROENDOCRINE TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A role for endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) in evaluation of suspected pancreatic neuroendocrine tumors has been described.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One series included 33 patients who underwent preoperative EUS FNA in whom the diagnosis was confirmed at surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/8\">",
"       8",
"      </a>",
"      ]. EUS detected 32 of the 33 lesions (97 percent), establishing a diagnosis in 30 patients. Sensitivity, specificity, positive, and negative predictive values were 83, 86, 95, and 60 percent, respectively. There was one false-positive and four false-negative diagnoses.",
"     </li>",
"     <li>",
"      A second study that included 39 patients found a sensitivity of EUS for diagnosing pancreatic neuroendocrine tumors of 68 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/9\">",
"       9",
"      </a>",
"      ]. There were no false-positive results in that study. In addition, when samples that were described as being atypical were considered positive, the sensitivity increased to 80 percent.",
"     </li>",
"     <li>",
"      A third study included 92 patients with pancreatic neuroendocrine tumors who underwent EUS, 82 of whom also underwent EUS FNA [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/10\">",
"       10",
"      </a>",
"      ]. The overall sensitivity of EUS FNA for the diagnosis of pancreatic neuroendocrine tumors was 87 percent. The sensitivity increased to 95 percent for malignant pancreatic neuroendocrine tumors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that EUS FNA may be helpful for establishing a preoperative diagnosis and in guiding the choice of operation, but cannot exclude the presence of a pancreatic neuroendocrine tumor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18330?source=see_link\">",
"     \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379237\">",
"    <span class=\"h1\">",
"     PANCREATIC CYSTIC LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) of pancreatic and peripancreatic cysts permits fluid analysis, while also obtaining detailed imaging information. Up to 10 percent of pancreatic cystic lesions are neoplastic, many of which are initially misdiagnosed as pseudocysts [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/11\">",
"     11",
"    </a>",
"    ]. Some pancreatic cystic tumors are malignant (cystadenocarcinoma) or have malignant potential (eg, mucinous cystic neoplasm, intraductal papillary mucinous neoplasm), whereas others have little or no malignant potential (eg, serous cystadenoma, retention cyst) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/20/15686?source=see_link\">",
"     \"Classification of pancreatic cysts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3368?source=see_link\">",
"     \"Pancreatic cystic neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distinguishing among these subtypes can occasionally be done by morphologic criteria alone, although no endosonographic features have proven to be consistently reliable for distinguishing benign from malignant lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Sampling tissue or cyst fluid can be helpful in patients in whom the diagnosis is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. A number of studies on tissue or fluid samples are useful for establishing a diagnosis, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determination of tumor antigens (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3368?source=see_link&amp;anchor=H11#H11\">",
"       \"Pancreatic cystic neoplasms\", section on 'Tumor markers'",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/17-20\">",
"       17-20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Determination of cyst fluid viscosity [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Detection of mucin-containing goblet cells or a strongly positive mucin stain, which suggests intraductal papillary mucinous tumor, mucinous cystic neoplasm, or mucinous cystadenocarcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/11,21\">",
"       11,21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Analysis of genetic mutations associated with tumors (eg, in one small study, K-ras mutations were absent in all cases of serous cystic neoplasms and present in all cases of cystadenocarcinoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A high amylase concentration suggests a pseudocyst or retention cyst, although there are case reports of an elevated amylase in patients with cystic neoplasms [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/11,23\">",
"       11,23",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is our current practice to send fluid for amylase, carcinoembryonic antigen, mucin stain, and cytology. However, it is important to stress that the negative predictive value of fluid analysis is not adequate to exclude malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/24\">",
"     24",
"    </a>",
"    ]. Furthermore, there is a small theoretical risk of causing bleeding, pancreatitis, or infection when performing EUS FNA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379244\">",
"    <span class=\"h1\">",
"     PERI-INTESTINAL LYMPHADENOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have documented that endosonography is useful for the evaluation of peri-intestinal lymph nodes, and may be more accurate than computed tomographic (CT) scanning (",
"    <a class=\"graphic graphic_table graphicRef50732 \" href=\"UTD.htm?29/32/30220\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/25-31\">",
"     25-31",
"    </a>",
"    ]. An illustrative series included 62 patients with esophageal cancer who were considered to have resectable tumors by CT scanning. Findings on endoscopic ultrasound (EUS) and CT were compared, with pathologic verification of celiac axis lymph nodes as the gold standard. Compared with CT scanning, EUS-guided fine-needle aspiration (EUS FNA) had a much higher sensitivity for malignant lymph nodes (72 versus 8 percent), while the overall specificity was comparable (97 versus 100 percent). False negative results with EUS were more likely in patients with T3 tumors (masses extending to the adventitia) and were observed only with microscopic metastases. Thus, EUS FNA has the potential to increase the diagnostic stage in patients in whom surgery is being contemplated, which may influence the treatment strategy.",
"   </p>",
"   <p>",
"    EUS FNA may also be useful for the diagnosis of other disorders associated with enlarged peri-intestinal and peri-esophageal lymph nodes such as Hodgkin's and non-Hodgkin lymphoma, particularly if flow cytometry is used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Cytology can be used to diagnose large cell non-Hodgkin lymphoma but is more limited in low-grade lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379251\">",
"    <span class=\"h1\">",
"     MEDIASTINAL LYMPHADENOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The esophagus provides a window for biopsying lesions arising from the posterior mediastinum such as subcarinal, aortopulmonic, and peri-esophageal lymph nodes (",
"    <a class=\"graphic graphic_picture graphicRef73773 \" href=\"UTD.htm?23/51/24371\">",
"     picture 1",
"    </a>",
"    ).The role of endoscopic ultrasound-guided fine-needle aspiration in this setting is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12552?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379258\">",
"    <span class=\"h1\">",
"     MUCOSAL AND SUBMUCOSAL LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) for the diagnosis of mucosal and submucosal lesions is limited to relatively small series (",
"    <a class=\"graphic graphic_table graphicRef71822 \" href=\"UTD.htm?41/35/42555\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/1,26,35\">",
"     1,26,35",
"    </a>",
"    ]. In one of the largest series, EUS FNA was performed on 103 lesions arising from the gastrointestinal wall (excluding stromal tumors) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/26\">",
"     26",
"    </a>",
"    ]. Sensitivity varied with the type of lesion (eg, 89 percent for non-Hodgkin's gastric lymphoma compared with 40 percent for gastric adenocarcinoma). EUS FNA of gastrointestinal wall lesions was correct in 24 of 36 cases (67 percent) in which endoscopic biopsies had previously failed.",
"   </p>",
"   <p>",
"    Cytologic assessment of gastrointestinal stromal tumors has not yet been demonstrated to reliably identify low-grade malignant lesions. Furthermore, although few data are available, EUS FNA does not appear to provide adequate tissue to allow differentiation of benign from malignant stromal lesions of the gastrointestinal tract.",
"   </p>",
"   <p>",
"    The combined use of cytologic analysis and immunohistochemistry for KIT mutations may permit the diagnosis of some of gastrointestinal stromal tumors (GISTs) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/36-42\">",
"     36-42",
"    </a>",
"    ]. In one study of 65 patients undergoing EUS-FNA for an upper gastrointestinal tract submucosal lesion over a four-year period, EUS-FNA with combined cytologic and immunohistochemical analysis was diagnostic in 45 of 66 lesions (68 percent), suspicious ini 8 (12 percent) and non-diagnostic in 13 (20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/42\">",
"     42",
"    </a>",
"    ]. Among the 28 lesions with a definitive pathologic diagnosis, the sensitivity of EUS-FNA for diagnosis of GIST was 82 percent, and the specificity was 100 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379265\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The close proximity of the intestinal tract to mediastinal and abdominal organs raises the possibility of endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) of other structures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    body fluids.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although limited to case reports, the drainage of pleural or ascitic fluid at the time of EUS is possible, and can be helpful if positive for malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/43-45\">",
"       43-45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Biopsy of solid liver lesions can be accomplished from the stomach with EUS [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/26,46-48\">",
"       26,46-48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      EUS FNA of an adrenal mass has been reported in a patient in whom CT-guided FNA was unsuccessful [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      EUS FNA of mediastinal lymph nodes can be helpful for diagnosis of sarcoidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/50\">",
"       50",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      EUS FNA permitted diagnosis of proximal biliary strictures after negative ERCP and brush cytology [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A systematic review and meta-analysis found that EUS FNA was 84 percent sensitive and 100 percent specific for diagnosing bile duct and gallbladder cancers [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/52\">",
"       52",
"      </a>",
"      ]; however, some treatment protocols preclude the option of liver transplantation when a transduodenal biopsy is undertaken of a primary cholangiocarcinoma, and therefore EUS FNA should be reserved in this setting for those patients who are not candidates for liver transplantation.",
"     </li>",
"     <li>",
"      Cancers metastatic to the pancreas can be visualized and biopsied [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379272\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least four large published series (that together included over 1450 patients) have found low complications rates from endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/26,54-56\">",
"     26,54-56",
"    </a>",
"    ]. In a large multicenter trial involving 554 consecutive mass or lymph node biopsies, only five complications were observed, all of which were nonfatal [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/26\">",
"     26",
"    </a>",
"    ]. Two patients had endoscope-induced perforation, two had febrile episodes following aspiration of cystic lesions, and one had hemorrhage from the wall of a pseudocyst. Major complications were observed in 2.5 percent of 355 patients who underwent EUS FNA for a solid pancreatic mass in another series [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/56\">",
"     56",
"    </a>",
"    ]. These included acute pancreatitis, infection, and sedation-related complications; there were no deaths. Pneumoperitoneum has been reported when endoscopy closely followed EUS FNA, suggesting that intestinal insufflation should be minimized or avoided for a short period (eg, two days) after EUS FNA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One concern with EUS FNA is seeding of the needle track with tumor cells. While rare, this has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/58-63\">",
"     58-63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of acute pancreatitis after biopsy of a pancreatic mass was estimated in a pooled analysis of 19 centers involving a total of 4909 EUS FNAs of solid pancreatic masses [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/64\">",
"     64",
"    </a>",
"    ]. Pancreatitis occurred after 14 procedures (0.29 percent). At two centers in which data were collected prospectively, the frequency of acute pancreatitis was 0.64 percent. Pancreatitis was classified as mild in 10 cases, moderate in 3, and severe in 1.",
"   </p>",
"   <p>",
"    The risk of bacteremia appears to be very low [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/65-67\">",
"     65-67",
"    </a>",
"    ], even with biopsy of solid rectal and perirectal lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/68\">",
"     68",
"    </a>",
"    ]. However, antibiotic prophylaxis has been recommended prior to FNA of cystic lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=see_link\">",
"     \"Antibiotic prophylaxis for gastrointestinal endoscopic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complication rates after biopsy of pancreatic cystic lesions appear to be similar to those observed after biopsy of solid lesions. In a series of 603 patients, complications were reported in 13 (2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A learning curve exists for EUS FNA, which may have bearing upon the likelihood of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/70\">",
"     70",
"    </a>",
"    ]. However, the optimal number of procedures that should be performed during training is unclear.",
"   </p>",
"   <p>",
"    Dilation of esophageal malignancy to permit passage of the endoscope carries a theoretical risk of perforation, although no perforations occurred in one study of 42 esophageal dilations for EUS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/71\">",
"     71",
"    </a>",
"    ]. False positive results (potentially leading to unnecessary surgery) are uncommon and mostly related to interpretation of cytologic material [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/72\">",
"     72",
"    </a>",
"    ]. Acute portal vein thrombosis following EUS FNA of pancreatic cancer was described in a case report [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3561/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109379509\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications for endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) include biopsy of mucosal and submucosal lesions in which prior conventional endoscopic biopsies have been nondiagnostic.",
"     </li>",
"     <li>",
"      EUS FNA has a role in the evaluation of a variety of lesions that are accessible from the gastrointestinal tract.",
"     </li>",
"     <li>",
"      Serious complications are uncommon, although a learning curve exists, which may have bearing upon the likelihood of complications.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/1\">",
"      Gress FG, Hawes RH, Savides TJ, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest Endosc 1997; 45:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/2\">",
"      Iglesias-Garcia J, Poley JW, Larghi A, et al. Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc 2011; 73:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/3\">",
"      Wallace MB, Kennedy T, Durkalski V, et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 2001; 54:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/4\">",
"      LeBlanc JK, Ciaccia D, Al-Assi MT, et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004; 59:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/5\">",
"      Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000; 51:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/6\">",
"      Van Dam J, Brady PG, Freeman M, et al. Guidelines for training in electronic ultrasound: guidelines for clinical application. From the ASGE. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1999; 49:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/7\">",
"      Eisen GM, Dominitz JA, Faigel DO, et al. Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc 2001; 54:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/8\">",
"      Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004; 60:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/9\">",
"      Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010; 71:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/10\">",
"      Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 2010; 71:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/11\">",
"      Warshaw AL, Compton CC, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990; 212:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/12\">",
"      Ahmad NA, Kochman ML, Lewis JD, Ginsberg GG. Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am J Gastroenterol 2001; 96:3295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/13\">",
"      Sedlack R, Affi A, Vazquez-Sequeiros E, et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002; 56:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/14\">",
"      Song MH, Lee SK, Kim MH, et al. EUS in the evaluation of pancreatic cystic lesions. Gastrointest Endosc 2003; 57:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/15\">",
"      Ahmad NA, Kochman ML, Brensinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc 2003; 58:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/16\">",
"      Brandwein SL, Farrell JJ, Centeno BA, Brugge WR. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc 2001; 53:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/17\">",
"      Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003; 98:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/18\">",
"      Hammel P, Levy P, Voitot H, et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995; 108:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/19\">",
"      Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/20\">",
"      Linder JD, Geenen JE, Catalano MF. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest Endosc 2006; 64:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/21\">",
"      Hammel PR, Forgue-Lafitte ME, L&eacute;vy P, et al. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas. Int J Cancer 1997; 74:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/22\">",
"      Bartsch D, Bastian D, Barth P, et al. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg 1998; 228:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/23\">",
"      Lumsden A, Bradley EL 3rd. Pseudocyst or cystic neoplasm? Differential diagnosis and initial management of cystic pancreatic lesions. Hepatogastroenterology 1989; 36:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/24\">",
"      Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc 2003; 58:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/25\">",
"      Chang KJ, Nguyen P, Erickson RA, et al. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997; 45:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/26\">",
"      Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/27\">",
"      Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/28\">",
"      Binmoeller KF, Brand B, Thul R, et al. EUS-guided, fine-needle aspiration biopsy using a new mechanical scanning puncture echoendoscope. Gastrointest Endosc 1998; 47:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/29\">",
"      Reed CE, Mishra G, Sahai AV, et al. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999; 67:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/30\">",
"      Lewis JD, Faigel DO, Dowdy Y, et al. Hodgkin's disease diagnosed by endoscopic ultrasound-guided fine needle aspiration of a periduodenal lymph node. Am J Gastroenterol 1998; 93:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/31\">",
"      Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am J Gastroenterol 2004; 99:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/32\">",
"      Ribeiro A, Vazquez-Sequeiros E, Wiersema LM, et al. EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma. Gastrointest Endosc 2001; 53:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/33\">",
"      Wiersema MJ, Gatzimos K, Nisi R, Wiersema LM. Staging of non-Hodgkin's gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry. Gastrointest Endosc 1996; 44:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/34\">",
"      Pilotti S, Di Palma S, Alasio L, et al. Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration. Acta Cytol 1993; 37:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/35\">",
"      Giovannini M, Seitz JF, Monges G, et al. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy 1995; 27:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/36\">",
"      Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 55:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/37\">",
"      Wieczorek TJ, Faquin WC, Rubin BP, Cibas ES. Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma. Cancer 2001; 93:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/38\">",
"      Fern&aacute;ndez-Esparrach G, Sendino O, Sol&eacute; M, et al. Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy 2010; 42:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/39\">",
"      Elliott DD, Fanning CV, Caraway NP. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors. Cancer 2006; 108:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/40\">",
"      Akahoshi K, Sumida Y, Matsui N, et al. Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol 2007; 13:2077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/41\">",
"      Avritscher R, Gupta S. Gastrointestinal stromal tumor: role of interventional radiology in diagnosis and treatment. Hematol Oncol Clin North Am 2009; 23:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/42\">",
"      Watson RR, Binmoeller KF, Hamerski CM, et al. Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors. Dig Dis Sci 2011; 56:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/43\">",
"      Chang KJ, Albers CG, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol 1995; 90:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/44\">",
"      Kaushik N, Khalid A, Brody D, McGrath K. EUS-guided paracentesis for the diagnosis of malignant ascites. Gastrointest Endosc 2006; 64:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/45\">",
"      DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine-needle aspiration of ascites. Clin Gastroenterol Hepatol 2007; 5:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/46\">",
"      Nguyen P, Feng JC, Chang KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 1999; 50:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/47\">",
"      DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 2003; 98:1976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/48\">",
"      Singh P, Erickson RA, Mukhopadhyay P, et al. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc 2007; 66:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/49\">",
"      Chang KJ, Erickson RA, Nguyen P. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration of the left adrenal gland. Gastrointest Endosc 1996; 44:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/50\">",
"      Annema JT, Veseli&ccedil; M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J 2005; 25:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/51\">",
"      DeWitt J, Misra VL, Leblanc JK, et al. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006; 64:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/52\">",
"      Wu LM, Jiang XX, Gu HY, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy in the evaluation of bile duct strictures and gallbladder masses: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2011; 23:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/53\">",
"      DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc 2005; 61:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/54\">",
"      Williams DB, Sahai AV, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/55\">",
"      O'Toole D, Palazzo L, Arot&ccedil;arena R, et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/56\">",
"      Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc 2006; 63:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/57\">",
"      Mergener K, Jowell PS, Branch MS, Baillie J. Pneumoperitoneum complicating ERCP performed immediately after EUS-guided fine needle aspiration. Gastrointest Endosc 1998; 47:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/58\">",
"      Katanuma A, Maguchi H, Hashigo S, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy 2012; 44 Suppl 2 UCTN:E160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/59\">",
"      Shah JN, Fraker D, Guerry D, et al. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc 2004; 59:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/60\">",
"      Paquin SC, Gari&eacute;py G, Lepanto L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc 2005; 61:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/61\">",
"      Doi S, Yasuda I, Iwashita T, et al. Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy. Gastrointest Endosc 2008; 67:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/62\">",
"      Hirooka Y, Goto H, Itoh A, et al. Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination. J Gastroenterol Hepatol 2003; 18:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/63\">",
"      Chong A, Venugopal K, Segarajasingam D, Lisewski D. Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc 2011; 74:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/64\">",
"      Eloubeidi MA, Gress FG, Savides TJ, et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc 2004; 60:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/65\">",
"      Barawi M, Gottlieb K, Cunha B, et al. A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/66\">",
"      Levy MJ, Norton ID, Wiersema MJ, et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. Gastrointest Endosc 2003; 57:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/67\">",
"      Janssen J, K&ouml;nig K, Knop-Hammad V, et al. Frequency of bacteremia after linear EUS of the upper GI tract with and without FNA. Gastrointest Endosc 2004; 59:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/68\">",
"      Levy MJ, Norton ID, Clain JE, et al. Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol 2007; 5:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/69\">",
"      Lee LS, Saltzman JR, Bounds BC, et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol 2005; 3:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/70\">",
"      Eloubeidi MA, Tamhane A. EUS-guided FNA of solid pancreatic masses: a learning curve with 300 consecutive procedures. Gastrointest Endosc 2005; 61:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/71\">",
"      Wallace MB, Hawes RH, Sahai AV, et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000; 51:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/72\">",
"      Schwartz DA, Unni KK, Levy MJ, et al. The rate of false-positive results with EUS-guided fine-needle aspiration. Gastrointest Endosc 2002; 56:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3561/abstract/73\">",
"      Matsumoto K, Yamao K, Ohashi K, et al. Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report. Gastrointest Endosc 2003; 57:269.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2656 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-201.211.0.116-511E52584A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3561=[""].join("\n");
var outline_f3_30_3561=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H109379509\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379500\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379195\">",
"      EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379202\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H109379209\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379216\">",
"      TRAINING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379223\">",
"      PANCREATIC MASSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379230\">",
"      PANCREATIC NEUROENDOCRINE TUMORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379237\">",
"      PANCREATIC CYSTIC LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379244\">",
"      PERI-INTESTINAL LYMPHADENOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379251\">",
"      MEDIASTINAL LYMPHADENOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379258\">",
"      MUCOSAL AND SUBMUCOSAL LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379265\">",
"      MISCELLANEOUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379272\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109379509\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2656\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2656|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/60/35778\" title=\"diagnostic image 1\">",
"      EUS liver metastasis FNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/18/17704\" title=\"diagnostic image 2\">",
"      EUS FNA esophageal CA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2656|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/51/24371\" title=\"picture 1\">",
"      EUS FNA esophageal TB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2656|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/32/8716\" title=\"table 1\">",
"      Linear scanning echoendoscopes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/32/30220\" title=\"table 2\">",
"      EUS FNA periintestinal nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/35/42555\" title=\"table 3\">",
"      EUS FNA submucosal lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=related_link\">",
"      Antibiotic prophylaxis for gastrointestinal endoscopic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/20/15686?source=related_link\">",
"      Classification of pancreatic cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18330?source=related_link\">",
"      Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=related_link\">",
"      Diagnosis and staging of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=related_link\">",
"      Endoscopic ultrasound guided trucut biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1929?source=related_link\">",
"      Endoscopic ultrasound in the staging of exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12552?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3368?source=related_link\">",
"      Pancreatic cystic neoplasms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_30_3562="Causes of hyponatremia";
var content_f3_30_3562=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of hyponatremia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3562/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3562/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3562/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3562/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/30/3562/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/30/3562/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/30/3562/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia is commonly defined as a serum sodium concentration below 135",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    but can vary to a small degree in different clinical laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/1\">",
"     1",
"    </a>",
"    ]. The dilutional fall in serum sodium is in most patients associated with a proportional reduction in the serum osmolality (ie, to a level below 275",
"    <span class=\"nowrap\">",
"     mosmol/kg),",
"    </span>",
"    but there are some exceptions. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Hyponatremia with a high or normal serum osmolality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In virtually all patients, hyponatremia results from the intake (either oral or intravenous) and subsequent retention of water [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/2\">",
"     2",
"    </a>",
"    ]. A water load will, in normal individuals, be rapidly excreted as the dilutional fall in serum osmolality suppresses the release of antidiuretic hormone (ADH, also called vasopressin) (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 1",
"    </a>",
"    ), thereby allowing excretion of the excess water in a dilute urine. The maximum attainable urine volume in normal individuals on a regular diet is over 10",
"    <span class=\"nowrap\">",
"     L/day.",
"    </span>",
"    This provides an enormous range of protection against the development of hyponatremia since the daily fluid intake in most healthy individuals is less than 2 to 2.5",
"    <span class=\"nowrap\">",
"     L/day.",
"    </span>",
"   </p>",
"   <p>",
"    In contrast to the response in normal individuals, patients who develop hyponatremia typically have an impairment in renal water excretion, most often due to an inability to suppress ADH secretion. An uncommon exception occurs in patients with primary polydipsia who can become hyponatremic because they drink such large quantities of fluid that they overwhelm the excretory capacity of the kidney even though ADH release is appropriately suppressed.",
"   </p>",
"   <p>",
"    An overview of the causes of hyponatremia will be presented here (",
"    <a class=\"graphic graphic_table graphicRef77603 \" href=\"UTD.htm?24/6/24684\">",
"     table 1",
"    </a>",
"    ). Most of the individual causes of hyponatremia are discussed in detail separately, as are issues related to the diagnosis and treatment of hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link\">",
"     \"Evaluation of the patient with hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link\">",
"     \"Overview of the treatment of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886104859\">",
"    <span class=\"h1\">",
"     DETERMINANTS OF THE SERUM SODIUM CONCENTRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Understanding the factors that determine the serum sodium concentration is required to appreciate the factors that promote the development of hyponatremia and what the composition of intravenous fluids must be to correct the hyponatremia.",
"   </p>",
"   <p>",
"    In the following discussion, the term \"tonicity\" (also called the effective plasma osmolality) refers to the activity of solutes that do not easily cross cell membranes and therefore determine the transcellular distribution of water.",
"   </p>",
"   <p>",
"    The extracellular and intracellular fluids are in osmotic equilibrium since water moves freely across most cell membranes. As a result, plasma tonicity is equal to the effective intracellular osmolality and to the effective osmolality of the total body water (TBW). These relationships can be summarized by the following equation:",
"   </p>",
"   <p>",
"    &nbsp;Plasma tonicity &nbsp;= &nbsp;(Extracellular solute &nbsp;+ &nbsp;Intracellular solute)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; TBW",
"   </p>",
"   <p>",
"    Exchangeable sodium salts (Nae) are the primary effective extracellular solute and exchangeable potassium (Ke) and its associated intracellular anions are the primary intracellular solutes; these solutes are the major determinants of the effective plasma osmolality. Glucose, the other major extracellular solute is, in the absence of marked hyperglycemia, present in a much lower molar concentration than sodium (eg, 5",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [90",
"    <span class=\"nowrap\">",
"     mg/dL]",
"    </span>",
"    versus 140",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    Approximately 30 percent of total body sodium and a smaller fraction of total body potassium are bound in areas such as bone where they are \"nonexchangeable\" and therefore not osmotically active. In addition, urea is considered an ineffective osmole, since it freely equilibrates across the cell membranes. When the plasma concentration of an ineffective osmole changes, the solute rapidly moves into or out of cells to equalize the concentrations. Thus, there is little or no water shift into or out of the cells as occurs with changes in the plasma sodium concentration.",
"   </p>",
"   <p>",
"    Thus, plasma tonicity (effective plasma osmolality) can be expressed as:",
"   </p>",
"   <p>",
"    &nbsp;Plasma tonicity &nbsp;&asymp; &nbsp; (2 x Nae &nbsp;+ &nbsp;2 x Ke)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;TBW",
"   </p>",
"   <p>",
"    The multiplier 2 accounts for the osmotic contributions of the anions accompanying sodium and potassium. In the absence of marked hyperglycemia or the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    , the above equation can be simplified to:",
"   </p>",
"   <p>",
"    &nbsp;2 x plasma Na &nbsp;&asymp; &nbsp;(2 x Nae &nbsp;+ &nbsp;2 x Ke)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;TBW",
"   </p>",
"   <p>",
"    and then to:",
"   </p>",
"   <p>",
"    &nbsp;Plasma Na &nbsp;&asymp; &nbsp;(Nae &nbsp;+ &nbsp;Ke)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;TBW",
"   </p>",
"   <p>",
"    As shown in the figure, this relationship applies over a wide range of plasma or serum sodium concentrations (",
"    <a class=\"graphic graphic_figure graphicRef71817 \" href=\"UTD.htm?42/31/43518\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886106456\">",
"    <span class=\"h2\">",
"     Application to hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of considering the effect of potassium on the plasma sodium concentration in patients with hyponatremia can be illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with hyponatremia induced by thiazide diuretics, the sodium plus potassium concentration in the urine may exceed that in the plasma, which will directly lower the plasma sodium concentration independent of fluid intake. (See",
"      <a class=\"local\" href=\"#H886104936\">",
"       'Diuretic-induced hyponatremia'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In a patient who has both severe hyponatremia and severe hypokalemia (due, for example, to diuretic therapy or vomiting), treatment with large amounts of potassium in addition to isotonic or hypertonic saline may lead to overly rapid correction of the hyponatremia and possible brain injury due to osmotic demyelination syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview of the treatment of hyponatremia\", section on 'Effect of potassium'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link&amp;anchor=H16#H16\">",
"       \"Overview of the treatment of hyponatremia\", section on 'Avoid overly rapid correction'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least two classification systems have been used for the etiology of hyponatremia with a low serum osmolality (defined as a serum osmolality less than 275",
"    <span class=\"nowrap\">",
"     mosmol/kg):",
"    </span>",
"    one stratifies patients according to whether circulating antidiuretic hormone (ADH) levels are inappropriately elevated or appropriately suppressed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/2\">",
"     2",
"    </a>",
"    ], and the other stratifies patients according to volume status (hypovolemia, normovolemia, or hypervolemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In either case, the development of hyponatremia requires the intake of water that cannot be excreted.",
"   </p>",
"   <p>",
"    The individual causes of hyponatremia are described below in the appropriate sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     According to serum ADH levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary excretion of a water load requires the suppression of ADH release, which is mediated by the reduction in serum osmolality (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 1",
"    </a>",
"    ). An inability to suppress ADH release is the most common cause of hyponatremia and can be seen in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      True volume depletion, which can be due to gastrointestinal losses (eg, vomiting or diarrhea) or renal losses (most often thiazide rather than loop diuretics)",
"     </li>",
"     <li>",
"      Decreased tissue perfusion (also called effective volume depletion) due to reduced cardiac output in heart failure or to systemic vasodilation in cirrhosis",
"     </li>",
"     <li>",
"      A primary (ie, not hypovolemic) increase in ADH release in the syndrome of inappropriate ADH secretion (SIADH), including an infrequent variant characterized by resetting of the osmostat.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are also disorders in which hyponatremia occurs despite appropriate suppression of ADH secretion. These include primary polydipsia, a low dietary solute intake, and advanced renal failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     According to volume status",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of hyponatremia can also be stratified by volume status [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypovolemia due to gastrointestinal losses (eg, vomiting or diarrhea) or renal losses (most often thiazide rather than loop diuretics)",
"     </li>",
"     <li>",
"      Normovolemia, which is most often associated with the SIADH but can also be seen with primary polydipsia and a low dietary solute intake",
"     </li>",
"     <li>",
"      Hypervolemia due to heart failure or cirrhosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyponatremia can also occur in patients with advanced renal failure. These patients may appear either euvolemic or, if they also retain salt and develop edema, hypervolemic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HYPONATREMIA WITH A LOW SERUM OSMOLALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum osmolality (Sosm) can be calculated by the concentration in millimoles per liter of the major serum solutes according to the following equation:",
"   </p>",
"   <p>",
"    &nbsp;Sosm",
"    <span class=\"nowrap\">",
"     (mmol/kg)",
"    </span>",
"    &nbsp;= &nbsp;(2 &nbsp;x &nbsp;serum [Na]) &nbsp;+ &nbsp;(serum",
"    <span class=\"nowrap\">",
"     [glucose]/18)",
"    </span>",
"    &nbsp;+ &nbsp;(blood urea",
"    <span class=\"nowrap\">",
"     nitrogen/2.8)",
"    </span>",
"   </p>",
"   <p>",
"    The serum sodium concentration is multiplied by two to account for the accompanying anions (mostly chloride and bicarbonate) that provide electroneutrality, and the corrections in the glucose concentration and blood urea nitrogen (BUN) are to convert",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    into",
"    <span class=\"nowrap\">",
"     mmol/L.",
"    </span>",
"    These corrections in glucose and BUN do not need to be made when standard units are used.",
"   </p>",
"   <p>",
"    The contributions of glucose and BUN to the serum osmolality are normally small, except in conditions such as diabetes mellitus and renal failure. Thus, the serum osmolality can be estimated in most patients by doubling the serum sodium concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=see_link&amp;anchor=H37261092#H37261092\">",
"     \"General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)\", section on 'Plasma osmolality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The two most common causes of hyponatremia with a low serum osmolality are effective arterial blood volume depletion and the syndrome of inappropriate antidiuretic hormone (ADH) secretion, both of which are associated with persistent ADH release [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with hyponatremia have a single cause but, in selected patients, multiple factors contribute to the fall in serum sodium. Symptomatic infection with human immunodeficiency virus (HIV) is an example of this phenomenon, as volume depletion, the syndrome of inappropriate ADH secretion, and adrenal insufficiency all may be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39332?source=see_link\">",
"     \"Electrolyte disturbances with HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Effective arterial blood volume depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term effective arterial blood volume (also called effective circulating volume) refers to the volume of arterial blood that is perfusing the tissues. Effective arterial blood volume depletion can occur by two mechanisms: true volume depletion; and edematous patients with heart failure or cirrhosis in whom tissue perfusion is reduced because of a low cardiac output or arterial vasodilation, respectively. The reduction in tissue perfusion is sensed by baroreceptors at three sites: in the carotid sinus and aortic arch that regulate sympathetic activity and, with significant volume depletion, the release of antidiuretic hormone; in the glomerular afferent arterioles that regulate the activity of the renin-angiotensin system; and in the atria and ventricles that regulate the release of natriuretic peptides. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=see_link&amp;anchor=H37261267#H37261267\">",
"     \"General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)\", section on 'Effective arterial blood volume'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Regardless of the mechanism, significantly decreased tissue perfusion is a potent stimulus to the secretion of ADH (",
"    <a class=\"graphic graphic_figure graphicRef58012 \" href=\"UTD.htm?2/33/2589\">",
"     figure 3",
"    </a>",
"    ). This response is mediated by baroreceptors in the carotid sinus, which sense a reduction in pressure or stretch, and can overcome the inhibitory effect of hyponatremia on ADH secretion. Thus, water retention and hyponatremia can develop in patients with any disorder causing effective arterial blood volume depletion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     True volume depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;True volume depletion can be caused by the loss of sodium and water from the gastrointestinal tract (eg, vomiting or diarrhea), in the urine (most often due to diuretic therapy), or bleeding. Such patients may also have hypokalemia and, if enough fluid is lost, azotemia due to decreased renal perfusion.",
"   </p>",
"   <p>",
"    The replacement of severe diarrhea losses due to cholera (which is associated with a sodium concentration in stool of 120 to 140",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    with an oral rehydration solution with reduced osmolality (ie, more free water) may result in an increased incidence of hyponatremia as compared to replacement with standard oral rehydration therapy, which has a higher sodium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18681?source=see_link\">",
"     \"Oral rehydration therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H886104936\">",
"    <span class=\"h4\">",
"     Diuretic-induced hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia, which can be severe, is an occasional complication of therapy with a thiazide diuretic that typically begins soon after the onset of thiazide therapy. In contrast, hyponatremia is only rarely induced by loop diuretics, since the inhibition of sodium chloride transport in the loop of Henle prevents the generation of the countercurrent gradient and therefore limits the ability of ADH to promote water retention.",
"   </p>",
"   <p>",
"    The following discussion will briefly review the mechanisms involved in thiazide-induced hyponatremia. A more complete discussion is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=see_link&amp;anchor=H2#H2\">",
"     \"Diuretic-induced hyponatremia\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although hypovolemia can contribute to thiazide-induced hyponatremia, most patients appear clinically euvolemic and several other factors appear to play a role in the development of hyponatremia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An underlying tendency to increased water intake.",
"     </li>",
"     <li>",
"      A reduction in diluting ability and there in water excretion, which is a direct effect of reduced sodium chloride reabsorption without water in the distal tubule.",
"     </li>",
"     <li>",
"      The sodium plus potassium concentration in the urine may exceed that in the plasma, which will directly lower the plasma sodium concentration (see",
"      <a class=\"local\" href=\"#H886104859\">",
"       'Determinants of the serum sodium concentration'",
"      </a>",
"      above). As an example, in a study of five patients with recent onset of severe thiazide-induced hyponatremia (mean serum sodium 105",
"      <span class=\"nowrap\">",
"       meq/L),",
"      </span>",
"      the urine sodium plus potassium concentration was 156",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Heart failure and cirrhosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even though the plasma and extracellular volumes may be markedly increased in heart failure and cirrhosis, the pressure sensed at the carotid sinus baroreceptors is reduced due to the fall in cardiac output in heart failure and to arterial vasodilatation in cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/2,10\">",
"     2,10",
"    </a>",
"    ]. Thus, serum ADH levels tend to vary with the severity of the underlying disease, making the development of hyponatremia an important prognostic sign. A stable serum sodium below 130",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    is a marker of near end-stage disease (",
"    <a class=\"graphic graphic_figure graphicRef55554 \" href=\"UTD.htm?29/6/29805\">",
"     figure 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38742?source=see_link\">",
"     \"Hyponatremia in patients with heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17608?source=see_link\">",
"     \"Hyponatremia in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison, hyponatremia is an uncommon finding in patients with the nephrotic syndrome in the absence of concurrent renal failure. Most such patients have relatively normal tissue perfusion and do not have a clinically important stimulus to ADH secretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36008?source=see_link&amp;anchor=H613074727#H613074727\">",
"     \"Pathophysiology and treatment of edema in patients with the nephrotic syndrome\", section on 'Volume regulatory hormones'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Syndrome of inappropriate ADH secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent ADH release and water retention can be seen in a variety of disorders that are not associated with hypovolemia, a condition called syndrome of inappropriate ADH secretion (SIADH). Major causes include central nervous system disease, malignancy, certain drugs, and post-surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Endocrine disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The original definition of SIADH excluded patients with abnormal adrenal and thyroid function [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. However, hyponatremia with features that are identical to those found in patients meeting the classical definition of SIADH (ie, euvolemia with a high urine osmolality and urine sodium) can also occur in patients with hypothyroidism or secondary adrenal insufficiency (not primary adrenal insufficiency, in which hyponatremia is associated with hypovolemia). Because these endocrine disorders are not always clinically apparent when patients first present with unexplained hyponatremia, some authors include endocrine disorders in the differential diagnosis of SIADH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88313973\">",
"    <span class=\"h3\">",
"     Hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia is sometimes associated with moderate to severe hypothyroidism, particularly in patients with primary hypothyroidism and myxedema [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/13-17\">",
"     13-17",
"    </a>",
"    ]. Thus, thyroid function should be evaluated in any patient with an otherwise unexplained reduction in the plasma sodium concentration. However, because hypothyroidism and hyponatremia are common findings in hospitalized patients, their coexistence may not necessarily be causal; other explanations for hyponatremia should still be sought unless hypothyroidism is severe.",
"   </p>",
"   <p>",
"    The mechanism by which hypothyroidism induces hyponatremia is incompletely understood. Patients with hypothyroidism have a diminished ability to excrete free water and fail to achieve maximally dilute urine after a water load. Some but not all studies have reported elevated levels of ADH in patients who have hyponatremia associated with hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. This may be due in part to a reduced cardiac output, which can lead to the release of ADH via the carotid sinus baroreceptors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/14,15,18\">",
"     14,15,18",
"    </a>",
"    ]. However, some patients fulfill criteria for SIADH since the urine sodium is not low as would be expected if a reduced cardiac output were responsible [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The glomerular filtration rate is also decreased in hypothyroidism. This can directly diminish free water excretion by diminishing water delivery to the diluting segments [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Decreased delivery may be particularly important in those cases in which hyponatremia develops despite appropriate suppression of ADH release [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Regardless of the mechanism, the net effect of the impairment in water excretion is the retention of ingested water and a reduction in the plasma sodium concentration by dilution.",
"   </p>",
"   <p>",
"    Some have questioned whether hypothyroidism deserves its traditional listing as a cause of hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/22\">",
"     22",
"    </a>",
"    ]. As an example, a study that compared 999 ambulatory patients with newly diagnosed hypothyroidism with 4875 euthyroid controls found no difference in serum sodium concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/23\">",
"     23",
"    </a>",
"    ]. In addition, none of the hypothyroid patients had a serum sodium concentration &lt;120",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    while two controls had hyponatremia of this severity. Although there was a statistical correlation between higher TSH levels and lower serum sodium concentrations, the slope of the relationship was clinically negligible. In contrast, symptomatic hyponatremia (with serum sodium concentrations ranging from 121 to 110",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    was reported in five patients with metastatic thyroid carcinoma after withdrawal of thyroid hormone replacement (withdrawn prior to administration of radioactive iodine) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/24\">",
"     24",
"    </a>",
"    ]. The serum sodium returned to normal after thyroid replacement was restarted. However, four of the five patients had known lung or cerebral metastases, which may have contributed to hyponatremia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88313980\">",
"    <span class=\"h3\">",
"     Adrenal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypersecretion of ADH seen with cortisol deficiency may be in part due to the reductions in systemic blood pressure and cardiac output (via an unknown mechanism) and the interruption of a negative feedback loop in which cortisol suppresses ADH release. In primary adrenal insufficiency (Addison disease), hypovolemia induced ADH secretion resulting from aldosterone deficiency also contributes. Secondary adrenal insufficiency (hypopituitarism), presents with euvolemic hyponatremia with biochemical features of SIADH. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=see_link\">",
"     \"Hyponatremia and hyperkalemia in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88313988\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The release of human chorionic gonadotropin during pregnancy may be responsible for a mild resetting of the osmostat downward that is responsible for a fall in the serum sodium concentration of about 5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24072?source=see_link\">",
"     \"Renal and urinary tract physiology in normal pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659218\">",
"    <span class=\"h2\">",
"     Ectopic ANP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although SIADH is more common, ectopic atrial natriuretic peptide production may be rarely associated with hyponatremia in some patients with small cell lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Exercise-associated hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marathon and ultramarathon runners can develop potentially severe hyponatremia that is primarily due to excessive water intake combined, in many cases, with impaired water excretion due to persistent ADH secretion. A similar sequence can occur during military operations and desert hikes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=see_link\">",
"     \"Exercise-associated hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4659391\">",
"    <span class=\"h2\">",
"     Ecstasy (MDMA) intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic and potentially fatal hyponatremia has been described after ingestion of the designer amphetamine ecstasy (methylenedioxymethamphetamine or MDMA) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/29-39\">",
"     29-39",
"    </a>",
"    ]. Two factors appear to be of primary importance in the development of hyponatremia: a marked increase in water intake [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/29,30,33\">",
"     29,30,33",
"    </a>",
"    ], such as with primary polydipsia; and drug-induced inappropriate secretion of ADH, which limits water excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/29,30,32-35,37\">",
"     29,30,32-35,37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Primary polydipsia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Hyponatremia is one of the major causes of death related to ecstasy use [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/39\">",
"     39",
"    </a>",
"    ]. As with other causes of hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/40\">",
"     40",
"    </a>",
"    ], young women with ecstasy-induced hyponatremia are more likely than men to develop severe neurologic complications such as coma and death [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/36,38\">",
"     36,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=see_link&amp;anchor=H7#H7\">",
"     \"Manifestations of hyponatremia and hypernatremia\", section on 'Susceptibility of premenopausal women'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link\">",
"     \"MDMA (ecstasy) intoxication\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hyponatremia despite appropriate suppression of ADH",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several conditions in which hyponatremia can occur despite suppression of ADH release: advanced renal failure, primary polydipsia, and low dietary solute intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Advanced renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative ability to excrete free water (free water excretion divided by the glomerular filtration rate) is not significantly impaired in patients with mild to moderate renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/41\">",
"     41",
"    </a>",
"    ]. Thus, normonatremia is usually maintained.",
"   </p>",
"   <p>",
"    In contrast, in advanced renal failure, the minimum urine osmolality rises to as high as 200 to 250",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    despite the appropriate suppression of ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/42\">",
"     42",
"    </a>",
"    ]. The osmotic diuresis induced by increased solute excretion per functioning nephron is thought to be responsible for the inability to dilute the urine.",
"   </p>",
"   <p>",
"    The impairment in free water excretion in advanced renal failure can lead to the retention of ingested water and the development of hyponatremia. Although the water retention will also lower the serum osmolality, this will be offset at least in part by the elevation in blood urea nitrogen (BUN). As a result, the measured serum osmolality may be normal or even increased, a finding that can also be seen in some other disorders. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Hyponatremia with a high or normal serum osmolality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, there is a difference between the measured serum osmolality and the effective serum osmolality. Urea is an ineffective osmole, since it can freely cross cell membranes and therefore does not obligate water movement out of the cells. Thus, patients with hyponatremia and renal failure have a low effective serum osmolality (Sosm) that becomes apparent if the measured Sosm is corrected for the effect of urea:",
"   </p>",
"   <p>",
"    &nbsp;Corrected Sosm &nbsp;= &nbsp;Measured Sosm &nbsp;- &nbsp;(BUN &nbsp;&divide; &nbsp;2.8)",
"   </p>",
"   <p>",
"    Dividing the BUN by 2.8 converts",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    into",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    which is required when measuring osmolality. In countries in which blood urea is measured in units of",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    the formula is:",
"   </p>",
"   <p>",
"    &nbsp;Corrected Sosm &nbsp;= &nbsp;Measured Sosm &nbsp;- &nbsp;blood urea concentration",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Primary polydipsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary polydipsia, a disorder in which there is a primary increase in thirst, is most often seen in patients with psychiatric illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/43-48\">",
"     43-48",
"    </a>",
"    ]. As an example, one study of 239 hospitalized patients with mental illness found that 6.6 percent had a history compatible with compulsive water drinking and that one-half of these had intermittent symptoms of hyponatremia due to transient water retention [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is presumed that a central defect in thirst regulation plays an important role in the pathogenesis of polydipsia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/46,50\">",
"     46,50",
"    </a>",
"    ]. In some cases, for example, the osmotic threshold for thirst is reduced",
"    <strong>",
"     below",
"    </strong>",
"    the threshold for the release of ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/51\">",
"     51",
"    </a>",
"    ]. In contrast to normal subjects in whom the thirst threshold is a roughly equal to or a few",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    <strong>",
"     higher",
"    </strong>",
"    than the threshold for ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/52\">",
"     52",
"    </a>",
"    ], these patients will continue to drink until the plasma osmolality is less than the threshold level. This may be difficult to achieve, however, since ADH secretion will be suppressed by the fall in plasma osmolality, resulting in rapid excretion of the excess water and continued stimulation of thirst. The mechanism responsible for abnormal thirst regulation in patients with primary polydipsia is unclear.",
"   </p>",
"   <p>",
"    Normal subjects can excrete more than 400 to 600 mL of urine per hour, a response that is mediated by suppression of ADH secretion and the subsequent formation of a dilute urine with a minimum osmolality between 40 and 100",
"    <span class=\"nowrap\">",
"     mosmol/kg.",
"    </span>",
"    If ADH regulation were intact, primary polydipsia should not lead to clinically important disturbances in the plasma sodium concentration unless intake were massively increased. Thus, the serum sodium concentration is usually normal or only slightly reduced in primary polydipsia since the excess water is readily excreted [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/44\">",
"     44",
"    </a>",
"    ]. These patients may be asymptomatic or present with complaints of polydipsia and polyuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=see_link\">",
"     \"Diagnosis of polyuria and diabetes insipidus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Water intake may occasionally exceed 400 to 600 mL per hour, particularly in institutionalized patients with severe psychosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/48\">",
"     48",
"    </a>",
"    ], and may produce fatal hyponatremia even though the urine is maximally dilute with an osmolality below 100",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Symptomatic hyponatremia can also be induced with an acute 3 to 4 liter water load (as may rarely be seen in anxious patients preparing for a radiologic examination or for urinary drug testing) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, some patients with polydipsia who become hyponatremic have a higher urine osmolality than polydipsic patients who remain normonatremic, indicating a concurrent increase in ADH release",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    response [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/43,50,56,57\">",
"     43,50,56,57",
"    </a>",
"    ]. A number of different abnormalities in ADH regulation have been identified in psychotic patients, each of which can impair water excretion. Studies in patients who have had at least one episode of hyponatremia have revealed the following defects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transient stimulation of ADH release during acute psychotic episodes, producing the syndrome of inappropriate ADH secretion (SIADH) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/56,58\">",
"       56,58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An increase in the net renal response to ADH so that, at the same plasma ADH levels, psychotic patients have a higher urine osmolality and therefore a lower rate of free water excretion than healthy controls [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/50\">",
"       50",
"      </a>",
"      ]. How this occurs is not known.",
"     </li>",
"     <li>",
"      Antipsychotic or antidepressant drugs (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      ) may also produce SIADH in a few patients. As examples,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      and fluoxetine can produce hyponatremia with a SIADH-like clinical picture [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/59,60\">",
"       59,60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A downward resetting of the osmostat regulating ADH release. As a result, a lower-than-normal plasma sodium concentration is required to completely suppress ADH release and excrete a water load. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=see_link\">",
"       \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Transient ADH release due to nausea [",
"      <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect is that some modestly hyponatremic patients with primary polydipsia do not have a maximally dilute urine as would be expected if ADH were appropriately suppressed by the fall in plasma osmolality and there were not increased sensitivity to ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/50\">",
"     50",
"    </a>",
"    ]. The likelihood of developing hyponatremia will be increased further if some other cause for enhanced ADH release is present, such as nausea, stress, or concurrent diuretic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/55,61\">",
"     55,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary polydipsia can also occur with hypothalamic lesions that affect the thirst center, as can be seen with infiltrative diseases such as sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/62\">",
"     62",
"    </a>",
"    ]. Low dietary solute intake can contribute to the development of hyponatremia by limiting water excretion even if the secretion of ADH is appropriately suppressed. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Low dietary solute intake'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As in any patient with polydipsia and polyuria, the possibility of diabetes insipidus should be considered in patients with psychiatric illness who present with these symptoms in the absence of hyponatremia. If compliance is possible, we recommend a water restriction test. An alternative in the uncooperative patient is to increase the plasma osmolality via a slow infusion of hypertonic saline. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=see_link\">",
"     \"Diagnosis of polyuria and diabetes insipidus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Measuring the urine osmolality is also important in patients who are hyponatremic. Pure primary polydipsia should be associated with appropriate suppression of ADH release and a urine osmolality below 100",
"    <span class=\"nowrap\">",
"     mosmol/kg.",
"    </span>",
"    A higher urine osmolality, which is often present, suggests at least a contributory role for increased ADH release or responsiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/43,50,57\">",
"     43,50,57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link\">",
"     \"Evaluation of the patient with hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no proven specific therapy for primary polydipsia with or without hyponatremia in psychotic patients. Acutely, limiting water intake will rapidly raise the plasma sodium concentration as the excess water is readily excreted in a dilute urine. The risk of inducing osmotic demyelination in this setting is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Over the long term, limiting the use of drugs that cause dry mouth, restricting fluid intake, and frequent weighing (to detect water retention) all may be helpful. Some physicians have tried the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    derivative",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/4/10310?source=see_link\">",
"     demeclocycline",
"    </a>",
"    , which induces reversible ADH resistance; however, this agent has not generally been effective [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=see_link\">",
"     \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Low dietary solute intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beer drinkers or other malnourished patients (including those with low-protein, high water intake diets) may have a marked reduction in water excretory capacity that is directly mediated by poor dietary intake [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. Ingestion of a normal diet results in the excretion of 600 to 900 mosmol of solute per day (primarily sodium and potassium salts and urea). Thus, if the minimum urine osmolality is 60",
"    <span class=\"nowrap\">",
"     mosmol/kg,",
"    </span>",
"    the maximum urine output will be 10 to 15",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    (eg, 900",
"    <span class=\"nowrap\">",
"     mosmol/day",
"    </span>",
"    &divide; 60",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    &nbsp;= 15 L).",
"   </p>",
"   <p>",
"    In contrast, beer contains little or no sodium, potassium, or protein, and the carbohydrate load will suppress endogenous protein breakdown and therefore urea excretion. As a result, daily solute excretion may fall below 250 mosmol, leading to a reduction in the maximum urine output to below 4",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    even though the urine is maximally dilute. Hyponatremia will ensue if more than this amount of fluid is taken in.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     HYPONATREMIA WITH A HIGH OR NORMAL SERUM OSMOLALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although hyponatremia is typically associated with a proportional reduction in serum osmolality (to a level below 275",
"    <span class=\"nowrap\">",
"     mosmol/kg),",
"    </span>",
"    some patients have a high (ie, greater than 295",
"    <span class=\"nowrap\">",
"     mosmol/kg)",
"    </span>",
"    or normal serum osmolality. One example, advanced renal failure, was described above. In that disorder, the associated elevation in blood urea nitrogen can counteract the fall in serum osmolality induced by hyponatremia. However, the effective serum osmolality is appropriately reduced in this setting since urea is an ineffective osmole. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Advanced renal failure'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the following sections on high and normal serum osmolality, the development of hyponatremia is linked to the factor that affects the serum osmolality. It is also possible that the factor that raises the serum osmolality is independent of the development of hyponatremia. One example of such an effect is alcohol ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/69\">",
"     69",
"    </a>",
"    ]. This will not cause hyponatremia but, in patients who are hyponatremic, significant alcohol ingestion can raise the serum osmolality to normal or high values. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=see_link&amp;anchor=H3#H3\">",
"     \"Serum osmolal gap\", section on 'Ethanol intoxication'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     High serum osmolality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia with a high serum osmolality is most often due to marked hyperglycemia in patients with diabetic ketoacidosis or hyperosmolar hyperglycemic state (also known as nonketotic hyperglycemia). Less common causes include the administration and subsequent retention of hypertonic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    or of maltose or sucrose when intravenous immune globulin is given in a maltose or sucrose solution to patients with renal failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32451?source=see_link\">",
"     \"Complications of mannitol therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=see_link\">",
"     \"General principles in the use of immune globulin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rise in serum osmolality induced by hyperglycemia,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    , maltose, or sucrose pulls water out of the cells, thereby lowering the serum sodium concentration by dilution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Marked hyperglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The changes that can occur in patients with marked hyperglycemia are discussed in detail elsewhere but will be briefly reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\", section on 'Serum sodium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physiologic calculations suggest that the serum sodium concentration should fall by 1",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    for every 62",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    rise in the serum glucose concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/70\">",
"     70",
"    </a>",
"    ]. However, this standard correction factor was not verified experimentally.",
"   </p>",
"   <p>",
"    In an attempt to address this issue, hyperglycemia was induced in six healthy subjects by the administration of both somatostatin (to block endogenous insulin secretion) and a hypertonic dextrose solution [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/71\">",
"     71",
"    </a>",
"    ]. A nonlinear relationship was observed between the changes in the glucose and sodium concentrations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The 1:62 ratio applied when the serum glucose concentration was less than 400",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (22.2",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      At higher glucose concentrations, there was a greater reduction in the serum sodium concentration (1:25 ratio, ie, a 4",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      reduction in serum sodium per 100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      further increase in serum glucose).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These calculations are idealized since they do not account for the osmotic diuresis typically induced by glucose excretion in the urine. The loss of water in excess of sodium and potassium will raise the serum sodium concentration. Some patients with uncontrolled diabetes have such a marked osmotic diuresis that, at presentation, the serum sodium concentration is increased and the serum osmolality is markedly elevated.",
"   </p>",
"   <p>",
"    The calculations are best used to estimate how much the serum sodium concentration will rise as the hyperglycemia is corrected. The administration of insulin drives glucose and water into the cells, reversing the initial direction of water movement and raising the serum sodium concentration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Normal serum osmolality",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Nonconductive irrigation solutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isosmotic hyponatremia can be produced by the addition of an isosmotic (or near isosmotic) but non-sodium-containing fluid to the extracellular space. This problem primarily results from the absorption of variable quantities of nonconductive glycine or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    irrigation solutions during transurethral resection of the prostate or bladder (called the transurethral resection syndrome) or during hysteroscopy or laparoscopic surgery.",
"   </p>",
"   <p>",
"    These patients may develop marked hyponatremia (below 110",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    and neurologic symptoms. Multiple factors can contribute to the neurologic symptoms, including the very low serum sodium concentration itself, glycine toxicity, and the accumulation of ammonia, serine, or glyoxalate from the metabolism of glycine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=see_link&amp;anchor=H16#H16\">",
"     \"Hyponatremia following transurethral resection or hysteroscopy\", section on 'Pathogenesis of neurologic symptoms'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"     \"Hysteroscopy: Managing fluid and gas distending media\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pseudohyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudohyponatremia, which is associated with a normal serum osmolality, refers to those disorders in which marked elevations in serum lipids or proteins result in a reduction in the fraction of serum that is water and an artificially low serum sodium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/30/3562/abstract/2,72,73\">",
"     2,72,73",
"    </a>",
"    ]. In normal subjects, the plasma water is approximately 93 percent of the plasma volume, with fats and proteins accounting for the remaining 7 percent. Thus, a normal plasma sodium concentration of 142",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (measured per liter of plasma) actually represents a concentration in the physiologically important plasma water of 153",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (142 &nbsp;&divide; &nbsp;0.93 &nbsp;= &nbsp;153).",
"   </p>",
"   <p>",
"    However, the plasma water fraction may fall below 80 percent in patients with marked hyperlipidemia (as with lactescent serum in uncontrolled diabetes mellitus) or hyperproteinemia (as in multiple myeloma). In these settings, the plasma water sodium concentration and plasma osmolality are unchanged, but the measured sodium concentration in the total plasma volume will be reduced since the specimen contains less plasma water. How pseudohyponatremia can be diagnosed is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link&amp;anchor=H5#H5\">",
"     \"Evaluation of the patient with hyponatremia\", section on 'Serum osmolality'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/20/9537?source=see_link\">",
"       \"Patient information: Hyponatremia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although the definition may vary slightly among clinical laboratories, hyponatremia is commonly defined as a serum sodium concentration below 135",
"      <span class=\"nowrap\">",
"       meq/L.",
"      </span>",
"      In virtually all patients, hyponatremia is due to the intake (either oral or intravenous) of water that cannot be excreted. This is usually accompanied by a proportional fall in serum osmolality (to a level below 275",
"      <span class=\"nowrap\">",
"       mosmol/kg)",
"      </span>",
"      but there are settings in the which the serum osmolality is high (greater than 295",
"      <span class=\"nowrap\">",
"       mosmol/kg)",
"      </span>",
"      or normal. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At least two classification systems have been used for the etiology of hyponatremia with a low serum osmolality: one stratifies patients according to whether circulating antidiuretic hormone (ADH) levels are inappropriately elevated or appropriately suppressed, and the other stratifies patients according to volume status (hypovolemia, normovolemia, or hypervolemia). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two major causes of hyponatremia with a low serum osmolality, both of which are associated with elevated serum ADH levels (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Hyponatremia with a low serum osmolality'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Effective arterial blood volume depletion, which may be associated with true volume depletion (due, for example, to gastrointestinal or renal losses, as with thiazide diuretics) or with hypervolemia in patients with heart failure or cirrhosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Effective arterial blood volume depletion'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Heart failure and cirrhosis cause hyponatremia despite increased plasma volume because the pressure sensed at the carotid sinus baroreceptors is reduced due to the fall in cardiac output in heart failure and to peripheral vasodilatation in cirrhosis. The rise in serum ADH levels varies with the severity of the disease, making the development of hyponatremia an important adverse prognostic sign. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Heart failure and cirrhosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normovolemia in the syndrome of inappropriate antidiuretic hormone secretion (SIADH). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Syndrome of inappropriate ADH secretion'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyponatremia with a low serum osmolality can also occur in a number of other settings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In association with hormonal changes, such adrenal insufficiency, hypothyroidism, the release of human chorionic gonadotropin during pregnancy, and ectopic production of atrial natriuretic peptide. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Endocrine disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In marathon and ultramarathon runners due to excessive water intake combined with impaired water excretion due to persistent ADH secretion. A similar sequence can occur during military operations and desert hikes. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Exercise-associated hyponatremia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite appropriate suppression of ADH release in patients with advanced renal failure, primary polydipsia, and low dietary solute intake. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Hyponatremia despite appropriate suppression of ADH'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyponatremia can also occur in patients with a high or normal serum osmolality; in addition to the following disorders which cause both hyponatremia and a high or normal serum osmolality, ethanol ingestion can raise the serum osmolality in patients who are hyponatremic for some other reason (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Hyponatremia with a high or normal serum osmolality'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hyponatremia with a high serum osmolality can be seen with hyperglycemia, advanced renal failure, or, less often, in association with the administration of hypertonic",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"       mannitol",
"      </a>",
"      or maltose. In advanced renal failure, the associated elevation in blood urea nitrogen can counteract the fall in serum osmolality induced by hyponatremia. However, the effective serum osmolality is appropriately reduced in this setting since urea is an ineffective osmole. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Advanced renal failure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyponatremia with a normal (or near-normal) serum osmolality can result from the addition of an isosmotic but non-sodium-containing fluid to the extracellular space, as occurs with the use of nonconductive glycine or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      flushing solutions during transurethral resection of the prostate or bladder. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Nonconductive irrigation solutions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pseudohyponatremia is defined as an artificially low serum sodium concentration associated with a normal serum osmolality due to marked elevations in lipids or proteins, resulting in a reduction in the water-containing fraction of serum. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Pseudohyponatremia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/1\">",
"      Adrogu&eacute; HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581.",
"     </a>",
"    </li>",
"    <li>",
"     Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.699.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/3\">",
"      Clayton JA, Le Jeune IR, Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM 2006; 99:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/4\">",
"      EDELMAN IS, LEIBMAN J, O'MEARA MP, BIRKENFELD LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/5\">",
"      Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985; 102:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/6\">",
"      Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987; 83:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/7\">",
"      Pham PC, Pham PM, Pham PT. Vasopressin excess and hyponatremia. Am J Kidney Dis 2006; 47:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/8\">",
"      Alam NH, Majumder RN, Fuchs GJ. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group. Lancet 1999; 354:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/9\">",
"      Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981; 70:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/10\">",
"      Schrier RW. An odyssey into the milieu int&eacute;rieur: pondering the enigmas. J Am Soc Nephrol 1992; 2:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/11\">",
"      Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356:2064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/12\">",
"      SCHWARTZ WB, BENNETT W, CURELOP S, BARTTER FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957; 23:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/13\">",
"      Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 2006; 17:1820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/14\">",
"      Derubertis FR Jr, Michelis MF, Bloom ME, et al. Impaired water excretion in myxedema. Am J Med 1971; 51:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/15\">",
"      Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet 1997; 350:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/16\">",
"      Schrier RW, Bichet DG. Osmotic and nonosmotic control of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders. J Lab Clin Med 1981; 98:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/17\">",
"      Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med 1978; 64:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/18\">",
"      Kreisman SH, Hennessey JV. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med 1999; 159:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/19\">",
"      Archambeaud-Mouveroux F, Dejax C, Jadaud JM, et al. [Myxedema coma with hypervasopressinism. 2 cases]. Ann Med Interne (Paris) 1987; 138:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/20\">",
"      Iwasaki Y, Oiso Y, Yamauchi K, et al. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab 1990; 70:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/21\">",
"      Schmitz PH, de Meijer PH, Meinders AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth J Med 2001; 58:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/22\">",
"      Kilpatrick ES. Disorders of sodium balance: hypothyroidism and hyponatraemia: an old wives' tale? BMJ 2006; 332:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/23\">",
"      Warner MH, Holding S, Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol (Oxf) 2006; 64:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/24\">",
"      Shakir MK, Krook LS, Schraml FV, et al. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid 2008; 18:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/25\">",
"      Davison JM, Shiells EA, Philips PR, Lindheimer MD. Influence of humoral and volume factors on altered osmoregulation of normal human pregnancy. Am J Physiol 1990; 258:F900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/26\">",
"      Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997; 156:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/27\">",
"      Chute JP, Taylor E, Williams J, et al. A metabolic study of patients with lung cancer and hyponatremia of malignancy. Clin Cancer Res 2006; 12:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/28\">",
"      Johnson BE, Damodaran A, Rushin J, et al. Ectopic production and processing of atrial natriuretic peptide in a small cell lung carcinoma cell line and tumor from a patient with hyponatremia. Cancer 1997; 79:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/29\">",
"      Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol 2008; 3:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/30\">",
"      Hartung TK, Schofield E, Short AI, et al. Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion. QJM 2002; 95:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/31\">",
"      Holmes SB, Banerjee AK, Alexander WD. Hyponatraemia and seizures after ecstasy use. Postgrad Med J 1999; 75:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/32\">",
"      Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after \"ecstasy\" (3,4-MDMA). Lancet 1996; 347:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/33\">",
"      Cherney DZ, Davids MR, Halperin ML. Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis. QJM 2002; 95:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/34\">",
"      Henry JA, Fallon JK, Kicman AT, et al. Low-dose MDMA (\"ecstasy\") induces vasopressin secretion. Lancet 1998; 351:1784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/35\">",
"      Wolff K, Tsapakis EM, Winstock AR, et al. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol 2006; 20:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/36\">",
"      Rosenson J, Smollin C, Sporer KA, et al. Patterns of ecstasy-associated hyponatremia in California. Ann Emerg Med 2007; 49:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/37\">",
"      Farah R, Farah R. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion. Pediatr Emerg Care 2008; 24:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/38\">",
"      Budisavljevic MN, Stewart L, Sahn SA, Ploth DW. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine (\"Ecstasy\") abuse. Am J Med Sci 2003; 326:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/39\">",
"      Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess 2009; 13:iii.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/40\">",
"      Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 1992; 117:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/41\">",
"      KLEEMAN CR, ADAMS DA, MAXWELL MH. An evaluation of maximal water diuresis in chronic renal disease. I. Normal solute intake. J Lab Clin Med 1961; 58:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/42\">",
"      Tannen RL, Regal EM, Dunn MJ, Schrier RW. Vasopressin-resistant hyposthenuria in advanced chronic renal disease. N Engl J Med 1969; 280:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/43\">",
"      Hariprasad MK, Eisinger RP, Nadler IM, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med 1980; 140:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/44\">",
"      BARLOW ED, DE WARDENER HE. Compulsive water drinking. Q J Med 1959; 28:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/45\">",
"      Rao KJ, Miller M, Moses A. Water intoxication and thioridazine (Mellaril). Ann Intern Med 1975; 82:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/46\">",
"      Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/47\">",
"      de Leon J. Polydipsia--a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci 2003; 253:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/48\">",
"      Kawai N, Baba A, Suzuki T, Shiraishi H. Roles of arginine vasopressin and atrial natriuretic peptide in polydipsia-hyponatremia of schizophrenic patients. Psychiatry Res 2001; 101:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/49\">",
"      Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry 1979; 136:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/50\">",
"      Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988; 318:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/51\">",
"      Thompson CJ, Edwards CR, Baylis PH. Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking. Clin Endocrinol (Oxf) 1991; 35:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/52\">",
"      Thompson CJ, Selby P, Baylis PH. Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. Am J Physiol 1991; 260:R533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/53\">",
"      LANGGARD H, SMITH WO. Self-induced water intoxication without predisposing illness. N Engl J Med 1962; 266:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/54\">",
"      Gillum DM, Linas SL. Water intoxication in a psychotic patient with normal renal water excretion. Am J Med 1984; 77:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/55\">",
"      Klonoff DC, Jurow AH. Acute water intoxication as a complication of urine drug testing in the workplace. JAMA 1991; 265:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/56\">",
"      Dubovsky SL, Grabon S, Berl T, Schrier RW. Syndrome of inappropriate secretion of antidiuretic hormone with exacerbated psychosis. Ann Intern Med 1973; 79:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/57\">",
"      Goldman MB, Robertson GL, Luchins DJ, Hedeker D. The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients. J Clin Endocrinol Metab 1996; 81:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/58\">",
"      Goldman MB, Robertson GL, Luchins DJ, et al. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 1997; 54:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/59\">",
"      Flegel KM, Cole CH. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med 1977; 87:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/60\">",
"      Cohen BJ, Mahelsky M, Adler L. More cases of SIADH with fluoxetine. Am J Psychiatry 1990; 147:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/61\">",
"      Levine S, McManus BM, Blackbourne BD, Roberts WC. Fatal water intoxication, schizophrenia, and diuretic therapy for systemic hypertension. Am J Med 1987; 82:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/62\">",
"      Stuart CA, Neelon FA, Lebovitz HE. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med 1980; 303:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/63\">",
"      Cheng JC, Zikos D, Skopicki HA, et al. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction. Am J Med 1990; 88:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/64\">",
"      Tanneau RS, Henry A, Rouhart F, et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry 1994; 55:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/65\">",
"      Alexander RC, Karp BI, Thompson S, et al. A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biol Psychiatry 1991; 30:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/66\">",
"      Hilden T, Svendsen TL. Electrolyte disturbances in beer drinkers. A specific \"hypo-osmolality syndrome\". Lancet 1975; 2:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/67\">",
"      Thaler SM, Teitelbaum I, Berl T. \"Beer potomania\" in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis 1998; 31:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/68\">",
"      Fox BD. Crash diet potomania. Lancet 2002; 359:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/69\">",
"      Purssell RA, Pudek M, Brubacher J, Abu-Laban RB. Derivation and validation of a formula to calculate the contribution of ethanol to the osmolal gap. Ann Emerg Med 2001; 38:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/70\">",
"      Katz MA. Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression. N Engl J Med 1973; 289:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/71\">",
"      Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/72\">",
"      Weisberg LS. Pseudohyponatremia: a reappraisal. Am J Med 1989; 86:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/30/3562/abstract/73\">",
"      Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003; 349:1465.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2374 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-190.92.87.115-3AD7EB5AF7-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3562=[""].join("\n");
var outline_f3_30_3562=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H886104859\">",
"      DETERMINANTS OF THE SERUM SODIUM CONCENTRATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H886106456\">",
"      Application to hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      According to serum ADH levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      According to volume status",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HYPONATREMIA WITH A LOW SERUM OSMOLALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Effective arterial blood volume depletion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - True volume depletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H886104936\">",
"      Diuretic-induced hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Heart failure and cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Syndrome of inappropriate ADH secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Endocrine disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88313973\">",
"      - Hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88313980\">",
"      - Adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88313988\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659218\">",
"      Ectopic ANP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Exercise-associated hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4659391\">",
"      Ecstasy (MDMA) intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hyponatremia despite appropriate suppression of ADH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Primary polydipsia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Low dietary solute intake",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      HYPONATREMIA WITH A HIGH OR NORMAL SERUM OSMOLALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      High serum osmolality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Marked hyperglycemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Normal serum osmolality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Nonconductive irrigation solutions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pseudohyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2374\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2374|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/61/15325\" title=\"figure 1\">",
"      Osmoregulation of ADH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/31/43518\" title=\"figure 2\">",
"      Determinants of plasma sodium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/33/2589\" title=\"figure 3\">",
"      Volume regulation of ADH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/6/29805\" title=\"figure 4\">",
"      Hyponatremia in HF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2374|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/6/24684\" title=\"table 1\">",
"      Major causes of hyponatremia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32451?source=related_link\">",
"      Complications of mannitol therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=related_link\">",
"      Diagnosis of polyuria and diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=related_link\">",
"      Diuretic-induced hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39332?source=related_link\">",
"      Electrolyte disturbances with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=related_link\">",
"      Evaluation of the patient with hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=related_link\">",
"      Exercise-associated hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=related_link\">",
"      General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=related_link\">",
"      Hyponatremia and hyperkalemia in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=related_link\">",
"      Hyponatremia following transurethral resection or hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17608?source=related_link\">",
"      Hyponatremia in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38742?source=related_link\">",
"      Hyponatremia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=related_link\">",
"      Hysteroscopy: Managing fluid and gas distending media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=related_link\">",
"      MDMA (ecstasy) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=related_link\">",
"      Manifestations of hyponatremia and hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18681?source=related_link\">",
"      Oral rehydration therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=related_link\">",
"      Overview of the treatment of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=related_link\">",
"      Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36008?source=related_link\">",
"      Pathophysiology and treatment of edema in patients with the nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/20/9537?source=related_link\">",
"      Patient information: Hyponatremia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24072?source=related_link\">",
"      Renal and urinary tract physiology in normal pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=related_link\">",
"      Serum osmolal gap",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=related_link\">",
"      Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_30_3563="Avoiding lead in soil PI";
var content_f3_30_3563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F61589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F61589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ways to prevent exposure to lead in soil",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Cover bare soil with grass, plants, gravel, or wood chips",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not let children play near walls of house or garage on bare soil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have children play in grassy area or sandbox that can be covered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wash children's hands after they play outside or play with pets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use a doormat to reduce track-in of outdoor dust and soil",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Environmental Protection Agency. Additional information available at:",
"     <a href=\"file://www.epa.gov/lead/\" target=\"_blank\">",
"      file://www.epa.gov/lead/",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3563=[""].join("\n");
var outline_f3_30_3563=null;
var title_f3_30_3564="Common headache syndromes in children and adolescents";
var content_f3_30_3564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of common headache syndromes in children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Migraine headache",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tension headache",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cluster headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Location",
"       </td>",
"       <td>",
"        Commonly bilateral in young children; in adolescents and young adults, unilateral in 60 to 70 percent and bifrontal or global in 30 percent",
"       </td>",
"       <td>",
"        Bilateral",
"       </td>",
"       <td>",
"        Always unilateral, usually begins around the eye or temple",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Characteristics",
"       </td>",
"       <td>",
"        Gradual in onset, crescendo pattern; pulsating; moderate or severe intensity; aggravated by routine physical activity",
"       </td>",
"       <td>",
"        Pressure or tightness that waxes and wanes",
"       </td>",
"       <td>",
"        Pain begins quickly, reaches a crescendo within minutes; pain is deep, continuous, excruciating, and explosive in quality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient appearance",
"       </td>",
"       <td>",
"        Patient prefers to rest in a dark, quiet room",
"       </td>",
"       <td>",
"        Patient may remain active or may need to rest",
"       </td>",
"       <td>",
"        Patient remains active",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration",
"       </td>",
"       <td>",
"        1 to 72 hours",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        30 minutes to 3 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Associated symptoms",
"       </td>",
"       <td>",
"        Nausea, vomiting, photophobia*, phonophobia*; may have aura (usually visual, but can involve other senses or cause speech or motor deficits)",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Ipsilateral lacrimation and redness of the eye; stuffy nose; rhinorrhea; pallor; sweating; Horner syndrome; focal neurologic symptoms rare; sensitivity to alcohol",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * May be inferred from the behavior of young children.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3564=[""].join("\n");
var outline_f3_30_3564=null;
var title_f3_30_3565="ACC AHA ESC anticoag cardiovert";
var content_f3_30_3565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA/ESC guideline summary: Prevention of thromboembolism in patients with atrial fibrillation (AF) undergoing cardioversion",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or",
"general agreement that the following approaches are effective for the",
"prevention of thromboembolism in patients with AF undergoing",
"cardioversion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; For AF duration of &ge;48 hours or duration unknown, anticoagulation with a goal INR of 2.0 to 3.0 for at least three weeks before and four weeks after either electrical or pharmacologic cardioversion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull;&nbsp; For AF duration of more than 48 hours that requires immediate cardioversion due to hemodynamic instability:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Unfractionated heparin should be given concurrently (unless contraindicated) by an initial intravenous bolus followed by a continuous infusion at a dose adjusted to prolong the activated partial thromboplastin time to 1.5 to 2.0 times control.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Thereafter, oral anticoagulation with a goal INR of 2.0 to 3.0 for at least four weeks as in patients undergo elective cardioversion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Limited data support the use of subcutaneous low molecular weight heparin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; For AF duration less than 48 hours associated with hemodynamic instability (as manifested by angina, myocardial infarction, shock, or pulmonary edema), immediate cardioversion should be performed with delay for prior initiation of anticoagulation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence",
"or opinion is in favor of the usefulness of the following approaches",
"for the prevention of thromboembolism in patients with AF undergoing",
"cardioversion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; During the 48 hours after the onset of AF, the need for anticoagulation before and after cardioversion may be based upon the patient's estimated risk of thromboembolism.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull;&nbsp; A reasonable alternative to anticoagulation prior to cardioversion is transesophageal echocardiography to look for thrombus in the left atrium or left atrial appendage:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. If thrombus is not identified, cardioversion is reasonable after initiation of unfractionated heparin (intravenous bolus followed by infusion at a dose adjusted to prolong the activated partial thromboplastin time to 1.5 to 2.0 times control).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Limited data support the use of subcutaneous low molecular weight heparin for this indication.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Heparin therapy is continued until oral anticoagulation with warfarin or other vitamin K antagonist has led to an INR &ge;2.0.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Oral anticoagulation with a goal INR of 2.0 to 3.0 is continued for a total duration of anticoagulation of at least four weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. If thrombus is present, oral anticoagulation with a goal INR of 2.0 to 3.0 for at least three weeks before and four weeks after restoration of sinus rhythm; a longer duration of anticoagulation may be appropriate even if cardioversion is successful, because the risk of thromboembolism often remains elevated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; For patients with atrial flutter undergoing cardioversion, anticoagulation according to the recommendations for AF.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 2006; 48:e149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3565=[""].join("\n");
var outline_f3_30_3565=null;
var title_f3_30_3566="Change BMD with add-back rx";
var content_f3_30_3566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Change in bone mineral density for women on GnRH agonists",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 308px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effects of GnRH agonist on bone density in women with endometriosis and pelvic pain. Women with endometriosis and pelvic pain were treated with the GnRH agonist leuprolide depot for 52 weeks. Group A received GnRH agonist plus placebo pills. Group B received GnRH agonist plus norethindrone acetate 5 mg daily. Group C received GnRH agonist and norethindrone acetate 5 mg and conjugated equine estrogens 0.625 mg daily, and group D received GnRH agonist and norethindrone acetate 5 mg and conjugated equine estrogens 1.25 mg daily. No significant bone density loss occurred in the groups which received the GnRH agonist plus low dose steroid add-back.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hornstein MD, Surrey ES, Weinberg GW, et al. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 1998; 91:16-24.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3566=[""].join("\n");
var outline_f3_30_3566=null;
var title_f3_30_3567="Edmonton symptom assessment";
var content_f3_30_3567=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Edmonton symptom assessment system: numeric scale",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 414px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_30_3567=[""].join("\n");
var outline_f3_30_3567=null;
